data_1ckz_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ckz _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.473 ' OD1' ' CG2' ' A' ' 12' ' ' VAL . 41.6 t-20 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.336 0.589 . . . . 0.0 109.602 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 30.7 mm -100.27 0.98 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.38 -0.825 . . . . 0.0 109.144 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.426 ' CG1' ' O ' ' A' ' 10' ' ' ILE . 6.2 tt -71.83 44.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.375 -0.828 . . . . 0.0 110.923 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 53.16 79.81 0.08 OUTLIER Glycine 0 N--CA 1.489 2.189 0 O-C-N 121.063 -1.023 . . . . 0.0 110.601 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.525 ' CG1' ' N ' ' A' ' 13' ' ' SER . 0.9 OUTLIER -91.77 -67.29 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.252 -1.146 . . . . 0.0 108.14 178.703 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.525 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 0.5 OUTLIER -75.15 105.15 6.02 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.712 -0.795 . . . . 0.0 108.978 179.865 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -85.89 -45.75 11.24 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.142 -0.974 . . . . 0.0 110.048 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -130.19 62.47 1.57 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.093 -1.004 . . . . 0.0 109.927 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.474 ' O ' ' HB2' ' A' ' 17' ' ' TYR . 2.0 tt0 -155.23 17.93 0.42 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.122 -0.986 . . . . 0.0 109.757 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.474 ' HB2' ' O ' ' A' ' 16' ' ' GLU . 0.1 OUTLIER 171.76 41.94 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.239 -0.913 . . . . 0.0 109.195 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -92.78 51.27 1.68 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.394 -0.816 . . . . 0.0 109.522 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 48.48 30.03 2.26 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.289 -0.882 . . . . 0.0 109.535 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.354 0 O-C-N 121.221 -0.925 . . . . 0.0 108.991 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.405 0.621 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.454 ' O ' ' N ' ' A' ' 11' ' ' GLY . 37.1 mm -84.4 2.39 3.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.382 -0.824 . . . . 0.0 108.953 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.403 ' O ' ' CG2' ' A' ' 10' ' ' ILE . 14.0 tt -66.11 45.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.495 -0.753 . . . . 0.0 110.635 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 9' ' ' ILE . . . 45.27 73.67 0.27 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.9 t -65.41 -61.65 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.21 -1.17 . . . . 0.0 109.052 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.1 p -73.49 70.79 1.29 Allowed 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.459 -0.897 . . . . 0.0 109.863 -178.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.07 -2.37 58.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.901 . . . . 0.0 109.747 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -154.76 55.31 0.67 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.189 -0.944 . . . . 0.0 109.51 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -161.74 -39.89 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.374 -0.829 . . . . 0.0 109.177 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -93.26 42.33 1.1 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.302 -0.874 . . . . 0.0 109.309 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.1 38.03 19.71 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.242 -0.911 . . . . 0.0 109.259 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.458 ' O ' ' C ' ' A' ' 20' ' ' ARG . 0.3 OUTLIER 66.41 6.24 4.22 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.503 -0.748 . . . . 0.0 109.933 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.489 ' O ' ' HG3' ' A' ' 20' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 121.522 0.677 . . . . 0.0 110.142 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.452 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.52 HD11 ' N ' ' A' ' 9' ' ' ILE . 1.5 mp -99.21 -19.38 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.252 -0.905 . . . . 0.0 109.076 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -120.15 29.68 2.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-O 121.759 0.79 . . . . 0.0 109.389 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.459 ' O ' ' N ' ' A' ' 13' ' ' SER . . . 64.3 4.36 12.09 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.461 HG13 ' N ' ' A' ' 13' ' ' SER . 1.2 t 67.34 -53.94 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 120.976 -1.308 . . . . 0.0 109.633 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.461 ' N ' HG13 ' A' ' 12' ' ' VAL . 0.1 OUTLIER -74.97 88.61 2.36 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.497 -0.752 . . . . 0.0 109.718 -179.08 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.51 ' CG ' ' O ' ' A' ' 14' ' ' TYR . 17.0 t80 -146.89 48.07 1.15 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.244 -0.91 . . . . 0.0 109.637 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -120.86 38.46 4.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.166 -0.959 . . . . 0.0 109.504 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -145.83 40.58 1.18 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.544 ' CB ' ' HB2' ' A' ' 20' ' ' ARG . 0.1 OUTLIER 49.28 41.38 20.13 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.511 -0.743 . . . . 0.0 109.098 -179.245 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.538 ' O ' ' CB ' ' A' ' 19' ' ' TYR . 6.2 ttt180 42.32 59.16 2.77 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.538 ' CB ' ' O ' ' A' ' 18' ' ' ARG . 22.5 t80 78.94 62.21 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -178.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.544 ' HB2' ' CB ' ' A' ' 17' ' ' TYR . 29.6 ttp180 . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.35 -0.844 . . . . 0.0 110.73 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.7 t30 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.197 0.522 . . . . 0.0 109.799 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.496 ' O ' ' C ' ' A' ' 10' ' ' ILE . 34.6 mm -122.89 -51.97 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.248 -0.907 . . . . 0.0 109.258 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.498 ' O ' ' CG2' ' A' ' 10' ' ' ILE . 9.2 tp 28.29 48.64 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.986 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 153.23 97.44 0.15 Allowed Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.594 -1.288 . . . . 0.0 110.097 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.559 ' CG1' ' N ' ' A' ' 13' ' ' SER . 2.5 t -105.93 -83.07 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.206 -1.173 . . . . 0.0 108.989 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.559 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 0.1 OUTLIER -68.25 92.42 0.41 Allowed 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.899 -0.721 . . . . 0.0 109.672 -179.185 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.23 47.3 2.01 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.218 -0.926 . . . . 0.0 109.387 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.453 ' CG ' ' O ' ' A' ' 15' ' ' ASP . 7.2 t70 54.2 61.61 2.96 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.105 -0.997 . . . . 0.0 108.702 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.585 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.9 OUTLIER -69.27 -33.89 73.92 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.147 -0.971 . . . . 0.0 108.944 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.585 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 96.9 m-85 -159.55 26.44 0.19 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.246 -0.909 . . . . 0.0 109.899 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.521 ' C ' ' O ' ' A' ' 17' ' ' TYR . 2.9 ttm180 27.42 43.91 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 120.976 0.417 . . . . 0.0 111.02 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.465 ' N ' ' O ' ' A' ' 17' ' ' TYR . 0.4 OUTLIER 69.66 51.41 0.46 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.031 -1.043 . . . . 0.0 109.262 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.496 ' N ' ' O ' ' A' ' 17' ' ' TYR . 36.4 ttp180 . . . . . 0 C--N 1.304 -1.401 0 O-C-N 121.287 -0.883 . . . . 0.0 109.121 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.491 ' C ' ' CD1' ' A' ' 9' ' ' ILE . 25.4 t-20 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.344 0.593 . . . . 0.0 109.715 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.491 ' CD1' ' C ' ' A' ' 8' ' ' ASN . 4.0 mp -147.49 -51.97 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.347 -0.846 . . . . 0.0 109.107 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.478 ' C ' ' O ' ' A' ' 9' ' ' ILE . 16.5 tt 35.43 42.68 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 121.355 0.598 . . . . 0.0 109.989 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -96.54 -17.61 33.06 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.829 -1.309 . . . . 0.0 109.829 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.513 ' CG1' ' N ' ' A' ' 13' ' ' SER . 42.9 t -68.63 -92.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.174 -1.192 . . . . 0.0 109.432 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.513 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 15.9 p 35.61 63.59 0.53 Allowed 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.166 0.508 . . . . 0.0 110.456 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.51 -53.71 2.63 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.261 -0.899 . . . . 0.0 109.276 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -131.76 46.85 2.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.4 -0.812 . . . . 0.0 109.174 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -82.44 -29.13 30.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.299 -0.876 . . . . 0.0 109.781 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.506 ' O ' ' C ' ' A' ' 18' ' ' ARG . 0.4 OUTLIER -112.58 42.2 1.88 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.21 -0.931 . . . . 0.0 109.716 -179.736 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.506 ' C ' ' O ' ' A' ' 17' ' ' TYR . 1.8 mpp_? 31.79 52.16 0.21 Allowed 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.25 0.547 . . . . 0.0 110.631 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.415 ' O ' ' C ' ' A' ' 20' ' ' ARG . 0.2 OUTLIER 48.17 60.28 3.71 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.272 -0.892 . . . . 0.0 109.206 -179.779 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.497 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 1.7 ttm180 . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.505 -0.747 . . . . 0.0 109.637 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 63.0 t30 . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 121.285 0.564 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.535 ' CG2' ' HB ' ' A' ' 12' ' ' VAL . 2.0 mp -47.5 -26.64 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.144 -0.972 . . . . 0.0 108.819 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.472 ' C ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER 33.31 35.76 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.371 0.605 . . . . 0.0 110.505 179.825 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 9' ' ' ILE . . . 95.14 100.14 1.76 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.535 ' HB ' ' CG2' ' A' ' 9' ' ' ILE . 2.1 t -126.48 -58.3 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.297 -1.119 . . . . 0.0 109.29 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 p -56.58 -173.45 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.766 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.99 -81.0 0.16 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.254 -0.903 . . . . 0.0 109.403 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.25 41.24 1.14 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -0.915 . . . . 0.0 109.677 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.451 ' O ' ' HB3' ' A' ' 17' ' ' TYR . 0.6 OUTLIER 54.21 18.2 1.72 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.284 -0.885 . . . . 0.0 109.793 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.451 ' HB3' ' O ' ' A' ' 16' ' ' GLU . 32.4 t80 69.02 38.97 1.86 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.144 -0.973 . . . . 0.0 109.451 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.428 ' O ' ' C ' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -88.77 42.59 1.09 Allowed 'General case' 0 C--N 1.3 -1.543 0 O-C-N 121.31 -0.869 . . . . 0.0 108.747 179.587 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.428 ' C ' ' O ' ' A' ' 18' ' ' ARG . 2.1 m-85 45.2 36.28 2.09 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.272 -0.893 . . . . 0.0 108.785 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.517 0 O-C-N 121.405 -0.81 . . . . 0.0 109.485 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 9' ' ' ILE . 30.0 t-20 . . . . . 0 N--CA 1.482 1.143 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.519 ' N ' ' OD1' ' A' ' 8' ' ' ASN . 31.2 mm -128.21 -7.55 3.8 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 O-C-N 121.464 -0.773 . . . . 0.0 109.973 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.1 tt -83.06 46.31 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.133 -0.979 . . . . 0.0 109.547 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -145.66 -101.57 0.31 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.525 HG13 ' N ' ' A' ' 13' ' ' SER . 53.8 t -127.54 -84.77 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.337 -1.096 . . . . 0.0 109.634 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.525 ' N ' HG13 ' A' ' 12' ' ' VAL . 0.1 OUTLIER 56.41 118.09 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.652 0.739 . . . . 0.0 110.145 -179.57 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.564 ' CG ' ' O ' ' A' ' 14' ' ' TYR . 24.7 t80 43.34 41.13 2.95 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.544 -0.722 . . . . 0.0 110.195 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 19' ' ' TYR . 18.8 t0 40.89 63.42 1.18 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.362 -0.836 . . . . 0.0 109.767 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.72 -3.26 30.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.03 -1.044 . . . . 0.0 109.984 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.45 ' O ' ' C ' ' A' ' 18' ' ' ARG . 26.0 m-85 -124.21 39.36 3.99 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.06 -1.025 . . . . 0.0 109.777 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.469 ' O ' ' N ' ' A' ' 20' ' ' ARG . 0.5 OUTLIER 41.92 32.91 0.31 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.658 0.742 . . . . 0.0 109.297 179.938 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.531 ' N ' ' OD1' ' A' ' 15' ' ' ASP . 2.0 t80 41.05 26.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.659 -0.651 . . . . 0.0 110.028 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.495 ' C ' ' O ' ' A' ' 19' ' ' TYR . 1.2 ttp180 . . . . . 0 N--CA 1.494 1.742 0 CA-C-O 121.473 0.654 . . . . 0.0 110.104 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.223 0.535 . . . . 0.0 110.034 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.582 ' CD1' ' N ' ' A' ' 9' ' ' ILE . 1.6 mp -110.16 -7.69 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.276 -0.89 . . . . 0.0 109.005 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.514 ' O ' HG21 ' A' ' 10' ' ' ILE . 4.6 tt 41.94 44.76 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-O 121.575 0.702 . . . . 0.0 110.164 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -86.38 49.42 4.07 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.462 ' O ' ' O ' ' A' ' 13' ' ' SER . 57.7 t -64.13 -87.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.422 -1.046 . . . . 0.0 109.98 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 12' ' ' VAL . 0.8 OUTLIER 43.99 95.1 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.362 0.601 . . . . 0.0 109.841 -179.27 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.592 ' CG ' ' O ' ' A' ' 14' ' ' TYR . 31.5 t80 -92.76 4.48 53.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 109.606 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.457 ' OD2' ' O ' ' A' ' 15' ' ' ASP . 6.6 t70 54.75 72.3 0.48 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.073 -1.017 . . . . 0.0 109.345 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.16 -13.86 37.43 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.528 ' C ' ' H ' ' A' ' 19' ' ' TYR . 16.0 t80 -123.49 69.01 1.02 Allowed 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 178.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.8 ttp85 -62.1 39.21 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.731 -0.606 . . . . 0.0 111.432 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.528 ' H ' ' C ' ' A' ' 17' ' ' TYR . 10.1 t80 -144.59 10.42 1.41 Allowed 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.454 ' O ' ' CG ' ' A' ' 20' ' ' ARG . 6.4 ttm180 . . . . . 0 N--CA 1.482 1.146 0 O-C-N 121.114 -0.991 . . . . 0.0 108.91 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 39.1 t30 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.059 0.457 . . . . 0.0 109.92 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.579 ' CD1' ' N ' ' A' ' 9' ' ' ILE . 3.3 mp -123.77 -31.14 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.039 -1.038 . . . . 0.0 109.881 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.516 ' C ' ' O ' ' A' ' 9' ' ' ILE . 0.6 OUTLIER 29.29 45.63 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 121.187 0.518 . . . . 0.0 110.66 179.773 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 9' ' ' ILE . . . -121.02 47.94 0.99 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.485 ' O ' ' N ' ' A' ' 14' ' ' TYR . 0.6 OUTLIER -81.91 -33.22 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.291 -1.123 . . . . 0.0 109.2 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 12' ' ' VAL . 7.4 m -42.41 97.08 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.936 -178.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.485 ' N ' ' O ' ' A' ' 12' ' ' VAL . 0.6 OUTLIER -121.58 -47.04 2.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.322 -0.861 . . . . 0.0 109.262 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.58 49.67 0.82 Allowed 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.263 -0.898 . . . . 0.0 109.098 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -48.36 -22.98 0.79 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.274 -0.891 . . . . 0.0 109.359 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.43 ' O ' ' C ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -114.86 37.55 3.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.202 -0.936 . . . . 0.0 109.304 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.43 ' C ' ' O ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER 39.75 33.07 0.12 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.569 -0.707 . . . . 0.0 110.094 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.471 ' O ' ' C ' ' A' ' 20' ' ' ARG . 0.4 OUTLIER 69.35 0.53 2.92 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.418 -0.801 . . . . 0.0 110.786 179.332 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.491 ' O ' ' HG3' ' A' ' 20' ' ' ARG . 2.5 tpm_? . . . . . 0 N--CA 1.489 1.482 0 O-C-N 121.365 -0.834 . . . . 0.0 109.615 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 121.376 0.608 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.492 ' O ' HG21 ' A' ' 10' ' ' ILE . 8.9 mm -78.27 -3.09 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.285 -0.884 . . . . 0.0 109.651 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.575 ' O ' ' CG2' ' A' ' 10' ' ' ILE . 0.3 OUTLIER 56.36 33.1 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-O 122.071 0.939 . . . . 0.0 109.708 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -151.78 -40.44 0.03 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.468 ' O ' ' O ' ' A' ' 13' ' ' SER . 0.5 OUTLIER -96.23 -19.56 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.425 -1.044 . . . . 0.0 108.821 179.568 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 12' ' ' VAL . 0.2 OUTLIER -54.4 -168.07 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.084 -178.29 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -114.93 5.13 14.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.331 -0.855 . . . . 0.0 109.8 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.72 52.91 0.74 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.083 -1.01 . . . . 0.0 109.636 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.454 ' OE1' HG13 ' A' ' 10' ' ' ILE . 20.2 tt0 -163.32 -55.51 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.226 -0.921 . . . . 0.0 109.555 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.516 ' O ' ' N ' ' A' ' 20' ' ' ARG . 0.3 OUTLIER -129.22 21.78 5.69 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.111 -0.993 . . . . 0.0 109.678 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.504 ' C ' ' O ' ' A' ' 17' ' ' TYR . 0.4 OUTLIER 30.66 42.47 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.139 0.495 . . . . 0.0 110.708 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.492 ' CD2' ' O ' ' A' ' 19' ' ' TYR . 71.2 t80 52.69 43.59 31.13 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.182 -0.949 . . . . 0.0 109.521 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.518 ' O ' ' CG ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.401 0 O-C-N 121.396 -0.815 . . . . 0.0 109.677 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.436 ' C ' HD11 ' A' ' 9' ' ' ILE . 20.0 t-20 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.309 0.576 . . . . 0.0 109.909 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.512 HD11 ' N ' ' A' ' 9' ' ' ILE . 4.2 mp -130.35 -64.43 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-O 121.877 0.846 . . . . 0.0 109.197 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.526 ' O ' ' CG2' ' A' ' 10' ' ' ILE . 0.9 OUTLIER -159.0 82.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.873 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 178.66 92.11 0.08 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.472 ' O ' ' O ' ' A' ' 13' ' ' SER . 87.9 t -95.29 -62.31 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.316 -1.108 . . . . 0.0 109.722 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.472 ' O ' ' O ' ' A' ' 12' ' ' VAL . 1.9 p -48.25 177.07 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.788 -178.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.44 ' O ' ' CD2' ' A' ' 14' ' ' TYR . 61.3 t80 -98.47 -1.51 41.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.33 -0.856 . . . . 0.0 109.664 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -108.86 29.24 7.65 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.235 -0.916 . . . . 0.0 109.665 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 58.75 9.7 1.24 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.548 -0.72 . . . . 0.0 110.864 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER 63.44 45.59 4.75 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 120.703 -1.248 . . . . 0.0 108.82 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.513 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -79.5 48.58 0.92 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.931 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.513 ' HB2' ' O ' ' A' ' 18' ' ' ARG . 0.5 OUTLIER 73.14 44.84 0.31 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.727 -0.608 . . . . 0.0 109.489 -179.426 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.468 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.405 0 O-C-N 121.343 -0.848 . . . . 0.0 108.851 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.419 ' O ' HD13 ' A' ' 9' ' ' ILE . 25.8 t-20 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.331 0.586 . . . . 0.0 109.51 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.445 HG23 HG13 ' A' ' 10' ' ' ILE . 2.3 mp -147.61 -54.02 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.272 -0.892 . . . . 0.0 109.183 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.445 HG13 HG23 ' A' ' 9' ' ' ILE . 13.6 mt -154.17 81.33 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -77.08 -2.85 79.87 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.508 ' O ' ' C ' ' A' ' 13' ' ' SER . 55.9 t -74.61 -93.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.096 -1.238 . . . . 0.0 109.763 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.508 ' C ' ' O ' ' A' ' 12' ' ' VAL . 0.7 OUTLIER 28.25 95.78 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 121.142 0.496 . . . . 0.0 110.987 -179.399 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.453 ' O ' ' C ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -84.67 -58.36 2.75 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.02 -1.05 . . . . 0.0 109.153 179.733 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.453 ' C ' ' O ' ' A' ' 14' ' ' TYR . 33.3 t0 40.02 40.43 0.75 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.634 -0.666 . . . . 0.0 109.774 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -173.79 -34.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.208 -0.933 . . . . 0.0 109.803 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.495 ' O ' ' N ' ' A' ' 20' ' ' ARG . 8.3 m-85 -117.79 31.68 6.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.171 -0.956 . . . . 0.0 109.468 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.479 ' C ' ' O ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER 31.87 49.41 0.12 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.217 0.532 . . . . 0.0 110.908 179.544 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.522 ' O ' ' CG ' ' A' ' 19' ' ' TYR . 11.3 t80 51.97 43.11 30.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.039 -1.038 . . . . 0.0 109.742 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.495 ' N ' ' O ' ' A' ' 17' ' ' TYR . 0.7 OUTLIER . . . . . 0 C--N 1.306 -1.298 0 O-C-N 121.187 -0.946 . . . . 0.0 109.105 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 19.3 t30 . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 121.257 0.551 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.446 ' O ' HD12 ' A' ' 10' ' ' ILE . 37.6 mm -78.51 -11.06 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.133 -0.979 . . . . 0.0 108.544 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.455 ' O ' ' CG2' ' A' ' 10' ' ' ILE . 33.2 mm -150.8 51.52 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -91.34 27.01 9.98 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.349 -1.101 . . . . 0.0 110.349 -178.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.485 HG13 ' N ' ' A' ' 13' ' ' SER . 1.0 OUTLIER -48.9 -48.78 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.098 -1.236 . . . . 0.0 108.884 179.54 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.485 ' N ' HG13 ' A' ' 12' ' ' VAL . 90.5 p -43.65 119.82 1.79 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.529 -0.732 . . . . 0.0 109.727 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' TYR . . . . . 0.444 ' O ' ' C ' ' A' ' 15' ' ' ASP . 0.1 OUTLIER -82.58 -30.88 29.29 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.262 -0.898 . . . . 0.0 109.516 179.851 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 14' ' ' TYR . 24.8 t70 41.94 46.61 3.57 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.446 -0.784 . . . . 0.0 109.457 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.599 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 7.8 tt0 -96.25 -51.14 4.51 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.392 -0.817 . . . . 0.0 108.858 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' TYR . . . . . 0.599 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 3.1 m-85 -177.27 32.95 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ARG . . . . . 0.487 ' C ' ' O ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER 35.75 33.55 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.651 0.739 . . . . 0.0 109.791 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' TYR . . . . . 0.493 ' N ' ' O ' ' A' ' 17' ' ' TYR . 0.2 OUTLIER 52.56 24.01 2.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.655 -0.653 . . . . 0.0 109.869 -179.934 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ARG . . . . . 0.433 ' HA ' ' HD2' ' A' ' 20' ' ' ARG . 29.2 tpt85 . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.048 -1.032 . . . . 0.0 110.563 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 120.677 0.275 . . . . 0.0 110.267 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -75.4 164.2 33.07 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.927 1.488 . . . . 0.0 110.333 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 92.52 -23.85 25.98 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.549 ' CG2' ' O ' ' A' ' 4' ' ' THR . 7.1 t -119.69 58.26 0.89 Allowed 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.464 -1.021 . . . . 0.0 109.829 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.517 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 1.1 tp -80.03 48.43 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.141 -0.975 . . . . 0.0 109.476 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -152.82 35.0 0.48 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.196 -0.94 . . . . 0.0 108.911 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -169.16 70.64 0.07 Allowed 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.473 ' OD1' ' CG2' ' A' ' 12' ' ' VAL . 41.6 t-20 -80.99 45.62 0.84 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.508 -0.745 . . . . 0.0 109.602 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 30.7 mm -100.27 0.98 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.38 -0.825 . . . . 0.0 109.144 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.426 ' CG1' ' O ' ' A' ' 10' ' ' ILE . 6.2 tt -71.83 44.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.375 -0.828 . . . . 0.0 110.923 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 53.16 79.81 0.08 OUTLIER Glycine 0 N--CA 1.489 2.189 0 O-C-N 121.063 -1.023 . . . . 0.0 110.601 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.525 ' CG1' ' N ' ' A' ' 13' ' ' SER . 0.9 OUTLIER -91.77 -67.29 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.252 -1.146 . . . . 0.0 108.14 178.703 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.525 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 0.5 OUTLIER -75.15 105.15 6.02 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.712 -0.795 . . . . 0.0 108.978 179.865 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -85.89 -45.75 11.24 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.142 -0.974 . . . . 0.0 110.048 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -130.19 62.47 1.57 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.093 -1.004 . . . . 0.0 109.927 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.474 ' O ' ' HB2' ' A' ' 17' ' ' TYR . 2.0 tt0 -155.23 17.93 0.42 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.122 -0.986 . . . . 0.0 109.757 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.474 ' HB2' ' O ' ' A' ' 16' ' ' GLU . 0.1 OUTLIER 171.76 41.94 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.239 -0.913 . . . . 0.0 109.195 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -92.78 51.27 1.68 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.394 -0.816 . . . . 0.0 109.522 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 48.48 30.03 2.26 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.289 -0.882 . . . . 0.0 109.535 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.44 39.38 1.83 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.221 -0.925 . . . . 0.0 108.991 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.61 31.65 5.28 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.492 -0.755 . . . . 0.0 109.124 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.532 HG11 ' CD1' ' A' ' 23' ' ' ILE . 14.7 p -92.84 -0.96 10.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.64 -0.663 . . . . 0.0 109.39 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.532 ' CD1' HG11 ' A' ' 22' ' ' VAL . 1.5 mp -122.52 42.2 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.187 -0.946 . . . . 0.0 109.377 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.4 161.03 0.13 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.309 -0.869 . . . . 0.0 109.603 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 118.047 -0.978 . . . . 0.0 109.406 179.962 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.531 ' N ' ' HD2' ' A' ' 2' ' ' PRO . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.791 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 1' ' ' MET . 43.7 Cg_endo -72.18 -163.67 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.741 1.39 . . . . 0.0 110.366 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -109.06 5.69 32.21 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.2 t -86.1 43.65 1.07 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.204 -1.174 . . . . 0.0 109.729 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.9 mm -110.02 44.6 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.174 -0.954 . . . . 0.0 109.159 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 179.29 51.26 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -96.3 58.41 1.79 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.537 -0.727 . . . . 0.0 109.073 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -76.45 47.71 0.49 Allowed 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.595 -0.691 . . . . 0.0 109.452 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.454 ' O ' ' N ' ' A' ' 11' ' ' GLY . 37.1 mm -84.4 2.39 3.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.382 -0.824 . . . . 0.0 108.953 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.403 ' O ' ' CG2' ' A' ' 10' ' ' ILE . 14.0 tt -66.11 45.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.495 -0.753 . . . . 0.0 110.635 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 9' ' ' ILE . . . 45.27 73.67 0.27 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.9 t -65.41 -61.65 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.21 -1.17 . . . . 0.0 109.052 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.1 p -73.49 70.79 1.29 Allowed 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.459 -0.897 . . . . 0.0 109.863 -178.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.07 -2.37 58.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.901 . . . . 0.0 109.747 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -154.76 55.31 0.67 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.189 -0.944 . . . . 0.0 109.51 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -161.74 -39.89 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.374 -0.829 . . . . 0.0 109.177 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -93.26 42.33 1.1 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.302 -0.874 . . . . 0.0 109.309 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.1 38.03 19.71 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.242 -0.911 . . . . 0.0 109.259 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.458 ' O ' ' C ' ' A' ' 20' ' ' ARG . 0.3 OUTLIER 66.41 6.24 4.22 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.503 -0.748 . . . . 0.0 109.933 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.489 ' O ' ' HG3' ' A' ' 20' ' ' ARG . 0.2 OUTLIER 35.33 40.41 0.07 Allowed 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 121.522 0.677 . . . . 0.0 110.142 179.634 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.7 p -105.12 37.45 2.18 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.209 -0.932 . . . . 0.0 108.932 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.485 ' CG2' ' O ' ' A' ' 22' ' ' VAL . 3.7 p -83.36 0.63 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.524 -0.735 . . . . 0.0 110.172 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.533 ' O ' ' CB ' ' A' ' 24' ' ' LYS . 11.2 mm -94.8 32.85 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.966 -1.084 . . . . 0.0 109.615 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.533 ' CB ' ' O ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER 158.37 56.4 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.649 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.457 -179.932 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.541 ' HB3' ' HD3' ' A' ' 2' ' ' PRO . 2.0 tpp . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 110.671 -0.122 . . . . 0.0 110.671 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.541 ' HD3' ' HB3' ' A' ' 1' ' ' MET . 47.5 Cg_endo -74.54 105.2 2.01 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.365 1.192 . . . . 0.0 110.377 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -157.58 166.58 33.86 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.834 -1.307 . . . . 0.0 109.834 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.0 t -89.89 40.21 0.99 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.344 -1.092 . . . . 0.0 109.55 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.432 HD12 HG22 ' A' ' 5' ' ' ILE . 13.4 mt -112.23 40.8 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.245 -0.909 . . . . 0.0 109.335 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.07 49.11 1.05 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.479 -0.763 . . . . 0.0 109.184 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 50.38 62.6 2.6 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.356 -0.84 . . . . 0.0 109.406 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.48 46.21 1.76 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.269 -0.895 . . . . 0.0 109.536 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.52 HD11 ' N ' ' A' ' 9' ' ' ILE . 1.5 mp -99.21 -19.38 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.252 -0.905 . . . . 0.0 109.076 179.859 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -120.15 29.68 2.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-O 121.759 0.79 . . . . 0.0 109.389 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.459 ' O ' ' N ' ' A' ' 13' ' ' SER . . . 64.3 4.36 12.09 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.461 HG13 ' N ' ' A' ' 13' ' ' SER . 1.2 t 67.34 -53.94 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 120.976 -1.308 . . . . 0.0 109.633 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.461 ' N ' HG13 ' A' ' 12' ' ' VAL . 0.1 OUTLIER -74.97 88.61 2.36 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.497 -0.752 . . . . 0.0 109.718 -179.08 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.51 ' CG ' ' O ' ' A' ' 14' ' ' TYR . 17.0 t80 -146.89 48.07 1.15 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.244 -0.91 . . . . 0.0 109.637 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -120.86 38.46 4.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.166 -0.959 . . . . 0.0 109.504 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -145.83 40.58 1.18 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.544 ' CB ' ' HB2' ' A' ' 20' ' ' ARG . 0.1 OUTLIER 49.28 41.38 20.13 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.511 -0.743 . . . . 0.0 109.098 -179.245 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.538 ' O ' ' CB ' ' A' ' 19' ' ' TYR . 6.2 ttt180 42.32 59.16 2.77 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.538 ' CB ' ' O ' ' A' ' 18' ' ' ARG . 22.5 t80 78.94 62.21 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -178.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.544 ' HB2' ' CB ' ' A' ' 17' ' ' TYR . 29.6 ttp180 -70.0 39.99 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.35 -0.844 . . . . 0.0 110.73 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.454 ' H ' ' C ' ' A' ' 19' ' ' TYR . 0.9 OUTLIER -117.38 22.61 12.34 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.659 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.422 ' O ' HG11 ' A' ' 22' ' ' VAL . 25.5 t -135.81 -28.04 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.141 -179.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.0 mp -118.1 54.99 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 121.252 -0.905 . . . . 0.0 109.284 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.1 tttt -85.59 56.73 4.09 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.29 -0.882 . . . . 0.0 109.587 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.508 179.862 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.0 mtm . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 120.783 0.325 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -73.91 171.84 17.08 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.054 1.555 . . . . 0.0 110.423 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -105.06 -118.28 4.45 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.531 ' O ' ' C ' ' A' ' 5' ' ' ILE . 13.9 t -106.06 34.62 3.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.212 -1.169 . . . . 0.0 109.491 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.585 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 2.8 mp 23.66 58.08 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 CA-C-O 121.845 0.831 . . . . 0.0 110.839 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' ' 7' ' ' GLU . 12.6 mttt 44.64 45.28 7.93 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.24 -0.913 . . . . 0.0 110.279 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 4' ' ' THR . 29.0 mt-10 41.17 56.58 3.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.303 -0.873 . . . . 0.0 110.053 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.7 t30 -115.49 43.39 2.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.107 -0.996 . . . . 0.0 109.799 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.496 ' O ' ' C ' ' A' ' 10' ' ' ILE . 34.6 mm -122.89 -51.97 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.248 -0.907 . . . . 0.0 109.258 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.498 ' O ' ' CG2' ' A' ' 10' ' ' ILE . 9.2 tp 28.29 48.64 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.986 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 153.23 97.44 0.15 Allowed Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.594 -1.288 . . . . 0.0 110.097 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.559 ' CG1' ' N ' ' A' ' 13' ' ' SER . 2.5 t -105.93 -83.07 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.206 -1.173 . . . . 0.0 108.989 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.559 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 0.1 OUTLIER -68.25 92.42 0.41 Allowed 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.899 -0.721 . . . . 0.0 109.672 -179.185 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.23 47.3 2.01 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.218 -0.926 . . . . 0.0 109.387 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.453 ' CG ' ' O ' ' A' ' 15' ' ' ASP . 7.2 t70 54.2 61.61 2.96 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.105 -0.997 . . . . 0.0 108.702 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.585 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.9 OUTLIER -69.27 -33.89 73.92 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.147 -0.971 . . . . 0.0 108.944 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.585 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 96.9 m-85 -159.55 26.44 0.19 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.246 -0.909 . . . . 0.0 109.899 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.521 ' C ' ' O ' ' A' ' 17' ' ' TYR . 2.9 ttm180 27.42 43.91 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 120.976 0.417 . . . . 0.0 111.02 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.465 ' N ' ' O ' ' A' ' 17' ' ' TYR . 0.4 OUTLIER 69.66 51.41 0.46 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.031 -1.043 . . . . 0.0 109.262 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.496 ' N ' ' O ' ' A' ' 17' ' ' TYR . 36.4 ttp180 -90.82 40.24 1.01 Allowed 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.287 -0.883 . . . . 0.0 109.121 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -89.3 34.55 0.8 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.403 -0.81 . . . . 0.0 108.926 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.452 ' O ' ' C ' ' A' ' 23' ' ' ILE . 46.3 t -130.65 59.41 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.51 -0.744 . . . . 0.0 109.685 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.581 ' CG2' ' O ' ' A' ' 23' ' ' ILE . 0.9 OUTLIER 37.38 73.52 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 CA-C-O 122.057 0.932 . . . . 0.0 109.942 179.182 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.472 ' O ' ' O ' ' A' ' 23' ' ' ILE . 10.2 mttp 43.39 99.54 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.415 -0.803 . . . . 0.0 110.586 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.097 -1.002 . . . . 0.0 109.173 179.38 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.531 ' N ' ' HD2' ' A' ' 2' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.759 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.531 ' HD2' ' N ' ' A' ' 1' ' ' MET . 44.0 Cg_endo -69.93 123.27 9.89 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.613 1.322 . . . . 0.0 110.468 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -89.14 -165.01 40.81 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.457 ' O ' ' C ' ' A' ' 5' ' ' ILE . 4.2 t -88.42 38.87 0.88 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.247 -1.149 . . . . 0.0 109.652 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.46 ' O ' HG13 ' A' ' 5' ' ' ILE . 8.1 tp 35.27 44.25 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.853 -0.529 . . . . 0.0 110.761 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.522 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 4.1 tptp -151.04 19.07 0.77 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.947 -1.095 . . . . 0.0 109.943 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.522 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 1.3 tt0 169.36 68.6 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.491 ' C ' ' CD1' ' A' ' 9' ' ' ILE . 25.4 t-20 -111.73 40.37 2.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.132 -0.98 . . . . 0.0 109.715 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.491 ' CD1' ' C ' ' A' ' 8' ' ' ASN . 4.0 mp -147.49 -51.97 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.347 -0.846 . . . . 0.0 109.107 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.478 ' C ' ' O ' ' A' ' 9' ' ' ILE . 16.5 tt 35.43 42.68 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 121.355 0.598 . . . . 0.0 109.989 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -96.54 -17.61 33.06 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.829 -1.309 . . . . 0.0 109.829 -179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.513 ' CG1' ' N ' ' A' ' 13' ' ' SER . 42.9 t -68.63 -92.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.174 -1.192 . . . . 0.0 109.432 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.513 ' N ' ' CG1' ' A' ' 12' ' ' VAL . 15.9 p 35.61 63.59 0.53 Allowed 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.166 0.508 . . . . 0.0 110.456 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.51 -53.71 2.63 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.261 -0.899 . . . . 0.0 109.276 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -131.76 46.85 2.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.4 -0.812 . . . . 0.0 109.174 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -82.44 -29.13 30.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.299 -0.876 . . . . 0.0 109.781 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.506 ' O ' ' C ' ' A' ' 18' ' ' ARG . 0.4 OUTLIER -112.58 42.2 1.88 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.21 -0.931 . . . . 0.0 109.716 -179.736 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.506 ' C ' ' O ' ' A' ' 17' ' ' TYR . 1.8 mpp_? 31.79 52.16 0.21 Allowed 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.25 0.547 . . . . 0.0 110.631 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.48 ' O ' HG22 ' A' ' 22' ' ' VAL . 0.2 OUTLIER 48.17 60.28 3.71 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.272 -0.892 . . . . 0.0 109.206 -179.779 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.497 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 1.7 ttm180 41.45 50.96 3.71 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.505 -0.747 . . . . 0.0 109.637 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.449 ' C ' ' O ' ' A' ' 20' ' ' ARG . 74.3 m 39.39 54.44 2.31 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.529 -0.732 . . . . 0.0 110.243 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.517 ' CG1' ' O ' ' A' ' 22' ' ' VAL . 78.3 t -110.29 44.89 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.238 -0.914 . . . . 0.0 109.07 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.429 ' O ' ' C ' ' A' ' 24' ' ' LYS . 3.4 mp -131.48 64.57 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.235 -0.916 . . . . 0.0 109.242 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 23' ' ' ILE . 21.2 ttpt -43.16 150.96 0.16 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.411 -0.806 . . . . 0.0 109.557 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.464 -179.949 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 120.839 0.352 . . . . 0.0 110.167 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.72 79.5 2.23 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.982 1.517 . . . . 0.0 110.38 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -99.1 -177.77 31.79 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.512 ' CG2' ' O ' ' A' ' 4' ' ' THR . 4.7 t -117.74 44.42 2.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.172 -1.193 . . . . 0.0 109.871 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.514 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 65.6 mt -128.51 67.78 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.143 -0.973 . . . . 0.0 109.767 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.99 39.98 3.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.382 -0.824 . . . . 0.0 108.957 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -126.96 42.0 3.41 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -98.78 43.81 1.05 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.455 -0.778 . . . . 0.0 109.588 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.535 ' CG2' ' HB ' ' A' ' 12' ' ' VAL . 2.0 mp -47.5 -26.64 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.144 -0.972 . . . . 0.0 108.819 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.472 ' C ' ' O ' ' A' ' 9' ' ' ILE . 0.0 OUTLIER 33.31 35.76 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.371 0.605 . . . . 0.0 110.505 179.825 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.487 ' N ' ' O ' ' A' ' 9' ' ' ILE . . . 95.14 100.14 1.76 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.535 ' HB ' ' CG2' ' A' ' 9' ' ' ILE . 2.1 t -126.48 -58.3 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.297 -1.119 . . . . 0.0 109.29 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.9 p -56.58 -173.45 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.766 -178.725 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.99 -81.0 0.16 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.254 -0.903 . . . . 0.0 109.403 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.25 41.24 1.14 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -0.915 . . . . 0.0 109.677 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.451 ' O ' ' HB3' ' A' ' 17' ' ' TYR . 0.6 OUTLIER 54.21 18.2 1.72 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.284 -0.885 . . . . 0.0 109.793 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.451 ' HB3' ' O ' ' A' ' 16' ' ' GLU . 32.4 t80 69.02 38.97 1.86 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.144 -0.973 . . . . 0.0 109.451 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.428 ' O ' ' C ' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -88.77 42.59 1.09 Allowed 'General case' 0 C--N 1.3 -1.543 0 O-C-N 121.31 -0.869 . . . . 0.0 108.747 179.587 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.428 ' C ' ' O ' ' A' ' 18' ' ' ARG . 2.1 m-85 45.2 36.28 2.09 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.272 -0.893 . . . . 0.0 108.785 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.9 37.48 0.97 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.405 -0.81 . . . . 0.0 109.485 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.4 m -144.2 28.8 1.34 Allowed 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.806 0.812 . . . . 0.0 108.86 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.534 ' O ' ' CG1' ' A' ' 22' ' ' VAL . 9.9 p -119.35 62.77 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-O 121.533 0.683 . . . . 0.0 109.401 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.579 ' O ' ' CG2' ' A' ' 23' ' ' ILE . 3.7 tp -76.59 41.89 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.075 -1.016 . . . . 0.0 110.708 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.424 ' HB2' ' O ' ' A' ' 23' ' ' ILE . 15.9 mtpt 62.53 73.22 0.47 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.662 -1.274 . . . . 0.0 109.308 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 117.933 -1.032 . . . . 0.0 109.477 -179.85 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.2 178.01 7.11 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.099 1.579 . . . . 0.0 110.337 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 133.96 -4.54 4.63 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 7.1 t -89.71 41.13 1.03 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.192 -1.181 . . . . 0.0 109.291 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 19.4 mm -141.13 64.18 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.382 -0.824 . . . . 0.0 109.236 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.494 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 0.3 OUTLIER -169.96 87.74 0.14 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.332 -0.855 . . . . 0.0 109.048 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.494 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 17.4 mt-10 76.35 95.2 0.07 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.402 -0.811 . . . . 0.0 109.172 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 9' ' ' ILE . 30.0 t-20 -99.82 -111.79 0.18 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.438 -0.789 . . . . 0.0 109.03 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.519 ' N ' ' OD1' ' A' ' 8' ' ' ASN . 31.2 mm -128.21 -7.55 3.8 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 O-C-N 121.464 -0.773 . . . . 0.0 109.973 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 1.1 tt -83.06 46.31 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.133 -0.979 . . . . 0.0 109.547 -179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -145.66 -101.57 0.31 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.525 HG13 ' N ' ' A' ' 13' ' ' SER . 53.8 t -127.54 -84.77 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.337 -1.096 . . . . 0.0 109.634 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.525 ' N ' HG13 ' A' ' 12' ' ' VAL . 0.1 OUTLIER 56.41 118.09 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.652 0.739 . . . . 0.0 110.145 -179.57 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.564 ' CG ' ' O ' ' A' ' 14' ' ' TYR . 24.7 t80 43.34 41.13 2.95 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.544 -0.722 . . . . 0.0 110.195 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 19' ' ' TYR . 18.8 t0 40.89 63.42 1.18 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.362 -0.836 . . . . 0.0 109.767 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.72 -3.26 30.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.03 -1.044 . . . . 0.0 109.984 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.45 ' O ' ' C ' ' A' ' 18' ' ' ARG . 26.0 m-85 -124.21 39.36 3.99 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.06 -1.025 . . . . 0.0 109.777 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.469 ' O ' ' N ' ' A' ' 20' ' ' ARG . 0.5 OUTLIER 41.92 32.91 0.31 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.658 0.742 . . . . 0.0 109.297 179.938 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.531 ' N ' ' OD1' ' A' ' 15' ' ' ASP . 2.0 t80 41.05 26.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.659 -0.651 . . . . 0.0 110.028 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.495 ' C ' ' O ' ' A' ' 19' ' ' TYR . 1.2 ttp180 33.07 40.18 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.473 0.654 . . . . 0.0 110.104 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.494 ' HB2' ' O ' ' A' ' 20' ' ' ARG . 25.8 t 168.13 52.85 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.468 -0.77 . . . . 0.0 109.409 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.413 ' O ' ' CG1' ' A' ' 22' ' ' VAL . 96.9 t -112.46 59.86 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.096 -1.002 . . . . 0.0 109.57 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.434 HD11 ' N ' ' A' ' 23' ' ' ILE . 4.5 mp -134.73 61.08 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.362 -0.836 . . . . 0.0 109.459 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.434 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 8.0 tptp 48.72 82.26 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.222 -0.924 . . . . 0.0 109.409 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . 0.4 ' O ' ' O ' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.488 1.456 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.524 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mtt . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -74.69 78.27 2.83 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.96 1.505 . . . . 0.0 110.229 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -164.44 169.16 39.12 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.8 t -86.12 47.7 1.5 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.264 -1.139 . . . . 0.0 109.432 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.43 ' O ' ' HG2' ' A' ' 6' ' ' LYS . 4.0 mm -106.59 56.63 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.302 -0.874 . . . . 0.0 109.566 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.43 ' HG2' ' O ' ' A' ' 5' ' ' ILE . 0.1 OUTLIER -146.28 71.42 1.25 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.276 -0.89 . . . . 0.0 109.196 179.988 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -86.58 50.57 2.03 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.43 -0.794 . . . . 0.0 109.128 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 47.5 t-20 -81.09 43.76 0.73 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.322 -0.861 . . . . 0.0 110.034 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.582 ' CD1' ' N ' ' A' ' 9' ' ' ILE . 1.6 mp -110.16 -7.69 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.276 -0.89 . . . . 0.0 109.005 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.514 ' O ' HG21 ' A' ' 10' ' ' ILE . 4.6 tt 41.94 44.76 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-O 121.575 0.702 . . . . 0.0 110.164 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -86.38 49.42 4.07 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.462 ' O ' ' O ' ' A' ' 13' ' ' SER . 57.7 t -64.13 -87.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.422 -1.046 . . . . 0.0 109.98 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.462 ' O ' ' O ' ' A' ' 12' ' ' VAL . 0.8 OUTLIER 43.99 95.1 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.362 0.601 . . . . 0.0 109.841 -179.27 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.592 ' CG ' ' O ' ' A' ' 14' ' ' TYR . 31.5 t80 -92.76 4.48 53.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 109.606 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.457 ' OD2' ' O ' ' A' ' 15' ' ' ASP . 6.6 t70 54.75 72.3 0.48 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.073 -1.017 . . . . 0.0 109.345 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.16 -13.86 37.43 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.528 ' C ' ' H ' ' A' ' 19' ' ' TYR . 16.0 t80 -123.49 69.01 1.02 Allowed 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 178.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.8 ttp85 -62.1 39.21 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.731 -0.606 . . . . 0.0 111.432 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.528 ' H ' ' C ' ' A' ' 17' ' ' TYR . 10.1 t80 -144.59 10.42 1.41 Allowed 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.59 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.454 ' O ' ' CG ' ' A' ' 20' ' ' ARG . 6.4 ttm180 -79.55 50.01 1.08 Allowed 'General case' 0 N--CA 1.482 1.146 0 O-C-N 121.114 -0.991 . . . . 0.0 108.91 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.1 t -78.65 45.39 0.58 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.124 -0.985 . . . . 0.0 109.011 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.45 ' O ' ' CG1' ' A' ' 22' ' ' VAL . 62.9 t -81.33 11.5 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.285 -0.884 . . . . 0.0 109.859 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.7 mp -84.29 44.44 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.115 -0.99 . . . . 0.0 109.599 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.0 mtpt -147.99 -179.98 7.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.287 -0.883 . . . . 0.0 109.221 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.515 -179.906 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.515 ' CB ' ' HD3' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.757 0 CA-C-O 120.809 0.338 . . . . 0.0 110.171 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.515 ' HD3' ' CB ' ' A' ' 1' ' ' MET . 47.3 Cg_endo -74.07 161.66 40.51 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.962 1.506 . . . . 0.0 110.58 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -136.15 -120.46 1.98 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.8 t -95.83 42.48 1.09 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.251 -1.147 . . . . 0.0 109.413 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.411 ' CD1' ' N ' ' A' ' 5' ' ' ILE . 3.3 mp -131.63 68.74 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.238 -0.914 . . . . 0.0 109.415 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -124.14 56.89 1.24 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.248 -0.908 . . . . 0.0 109.608 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 49.28 63.59 2.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.224 -0.923 . . . . 0.0 109.546 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 39.1 t30 -113.0 46.23 1.25 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.238 -0.914 . . . . 0.0 109.92 -179.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.579 ' CD1' ' N ' ' A' ' 9' ' ' ILE . 3.3 mp -123.77 -31.14 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.039 -1.038 . . . . 0.0 109.881 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.516 ' C ' ' O ' ' A' ' 9' ' ' ILE . 0.6 OUTLIER 29.29 45.63 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 121.187 0.518 . . . . 0.0 110.66 179.773 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 9' ' ' ILE . . . -121.02 47.94 0.99 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.485 ' O ' ' N ' ' A' ' 14' ' ' TYR . 0.6 OUTLIER -81.91 -33.22 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.291 -1.123 . . . . 0.0 109.2 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 12' ' ' VAL . 7.4 m -42.41 97.08 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.936 -178.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.485 ' N ' ' O ' ' A' ' 12' ' ' VAL . 0.6 OUTLIER -121.58 -47.04 2.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.322 -0.861 . . . . 0.0 109.262 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.58 49.67 0.82 Allowed 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.263 -0.898 . . . . 0.0 109.098 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -48.36 -22.98 0.79 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.274 -0.891 . . . . 0.0 109.359 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.43 ' O ' ' C ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -114.86 37.55 3.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.202 -0.936 . . . . 0.0 109.304 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.43 ' C ' ' O ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER 39.75 33.07 0.12 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.569 -0.707 . . . . 0.0 110.094 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.471 ' O ' ' C ' ' A' ' 20' ' ' ARG . 0.4 OUTLIER 69.35 0.53 2.92 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.418 -0.801 . . . . 0.0 110.786 179.332 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.491 ' O ' ' HG3' ' A' ' 20' ' ' ARG . 2.5 tpm_? 38.43 39.34 0.29 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.365 -0.834 . . . . 0.0 109.615 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.12 37.74 0.99 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.356 -0.84 . . . . 0.0 109.178 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.408 ' O ' HG11 ' A' ' 22' ' ' VAL . 72.4 t -141.04 72.92 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.417 -0.802 . . . . 0.0 109.64 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.434 ' O ' ' HE3' ' A' ' 24' ' ' LYS . 1.9 mp -99.17 43.96 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.16 -0.962 . . . . 0.0 109.426 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.434 ' HE3' ' O ' ' A' ' 23' ' ' ILE . 0.0 OUTLIER -143.18 106.3 4.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.429 -0.794 . . . . 0.0 109.365 179.888 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.411 -179.968 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.0 ttm . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -72.67 73.64 2.88 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.904 1.476 . . . . 0.0 110.325 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -169.26 159.71 32.75 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.511 ' O ' ' CG2' ' A' ' 4' ' ' THR . 14.6 t -101.17 56.38 0.85 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.359 -1.083 . . . . 0.0 109.023 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.457 ' O ' ' C ' ' A' ' 6' ' ' LYS . 1.8 mp -84.66 43.21 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.455 -0.778 . . . . 0.0 109.656 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 5' ' ' ILE . 14.1 tttt 40.04 42.52 1.13 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.5 -0.75 . . . . 0.0 109.838 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.419 ' OE2' HG12 ' A' ' 12' ' ' VAL . 11.4 tt0 50.36 64.29 1.86 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.204 -0.935 . . . . 0.0 109.404 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.457 ' HB3' HG23 ' A' ' 5' ' ' ILE . 4.5 t-20 -110.71 54.0 0.68 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.188 -0.945 . . . . 0.0 109.476 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.492 ' O ' HG21 ' A' ' 10' ' ' ILE . 8.9 mm -78.27 -3.09 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.285 -0.884 . . . . 0.0 109.651 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.575 ' O ' ' CG2' ' A' ' 10' ' ' ILE . 0.3 OUTLIER 56.36 33.1 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-O 122.071 0.939 . . . . 0.0 109.708 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -151.78 -40.44 0.03 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.468 ' O ' ' O ' ' A' ' 13' ' ' SER . 0.5 OUTLIER -96.23 -19.56 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.425 -1.044 . . . . 0.0 108.821 179.568 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 12' ' ' VAL . 0.2 OUTLIER -54.4 -168.07 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.084 -178.29 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -114.93 5.13 14.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.331 -0.855 . . . . 0.0 109.8 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.72 52.91 0.74 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.083 -1.01 . . . . 0.0 109.636 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.454 ' OE1' HG13 ' A' ' 10' ' ' ILE . 20.2 tt0 -163.32 -55.51 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.226 -0.921 . . . . 0.0 109.555 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.516 ' O ' ' N ' ' A' ' 20' ' ' ARG . 0.3 OUTLIER -129.22 21.78 5.69 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.111 -0.993 . . . . 0.0 109.678 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.504 ' C ' ' O ' ' A' ' 17' ' ' TYR . 0.4 OUTLIER 30.66 42.47 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.139 0.495 . . . . 0.0 110.708 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.492 ' O ' ' CD2' ' A' ' 19' ' ' TYR . 71.2 t80 52.69 43.59 31.13 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.182 -0.949 . . . . 0.0 109.521 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.518 ' CG ' ' O ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER 42.21 45.13 3.47 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.396 -0.815 . . . . 0.0 109.677 179.878 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.5 m -161.78 47.94 0.19 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.36 -0.838 . . . . 0.0 109.028 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.563 ' CG1' ' CD1' ' A' ' 23' ' ' ILE . 2.6 p -49.42 -25.27 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.397 -0.815 . . . . 0.0 109.657 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.579 ' CG2' ' O ' ' A' ' 23' ' ' ILE . 1.5 mp -89.82 52.35 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 O-C-N 121.164 -0.96 . . . . 0.0 108.54 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.466 ' HD3' ' O ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -76.22 149.01 37.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.132 -0.98 . . . . 0.0 109.338 -179.695 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.341 179.965 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 ttt . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 120.801 0.334 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -75.8 87.31 1.4 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.054 1.555 . . . . 0.0 110.616 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 128.38 137.45 4.38 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.851 -1.299 . . . . 0.0 109.851 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.482 ' O ' ' C ' ' A' ' 5' ' ' ILE . 8.9 t -93.92 36.61 1.1 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.19 -1.182 . . . . 0.0 109.287 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.489 HG22 ' O ' ' A' ' 5' ' ' ILE . 10.0 tp 33.2 48.34 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 121.324 0.583 . . . . 0.0 110.661 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 3.1 tptt -119.56 48.93 1.43 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.113 -0.992 . . . . 0.0 109.432 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . 0.598 ' CG ' ' O ' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -109.73 24.8 12.55 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 122.19 0.995 . . . . 0.0 109.187 179.922 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.436 ' C ' HD11 ' A' ' 9' ' ' ILE . 20.0 t-20 -101.93 39.56 1.45 Allowed 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.24 -0.913 . . . . 0.0 109.909 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.512 HD11 ' N ' ' A' ' 9' ' ' ILE . 4.2 mp -130.35 -64.43 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-O 121.877 0.846 . . . . 0.0 109.197 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.526 ' O ' ' CG2' ' A' ' 10' ' ' ILE . 0.9 OUTLIER -159.0 82.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.873 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 178.66 92.11 0.08 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.472 ' O ' ' O ' ' A' ' 13' ' ' SER . 87.9 t -95.29 -62.31 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.316 -1.108 . . . . 0.0 109.722 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.472 ' O ' ' O ' ' A' ' 12' ' ' VAL . 1.9 p -48.25 177.07 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.788 -178.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.44 ' CD2' ' O ' ' A' ' 14' ' ' TYR . 61.3 t80 -98.47 -1.51 41.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.33 -0.856 . . . . 0.0 109.664 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -108.86 29.24 7.65 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.235 -0.916 . . . . 0.0 109.665 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 58.75 9.7 1.24 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.548 -0.72 . . . . 0.0 110.864 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER 63.44 45.59 4.75 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 120.703 -1.248 . . . . 0.0 108.82 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.513 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -79.5 48.58 0.92 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.931 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.513 ' HB2' ' O ' ' A' ' 18' ' ' ARG . 0.5 OUTLIER 73.14 44.84 0.31 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.727 -0.608 . . . . 0.0 109.489 -179.426 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.468 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 0.1 OUTLIER -103.91 36.84 2.21 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.343 -0.848 . . . . 0.0 108.851 179.587 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -120.53 32.87 5.8 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.482 -0.761 . . . . 0.0 109.111 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.536 ' CG1' ' O ' ' A' ' 22' ' ' VAL . 95.4 t -92.27 46.23 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.633 -0.667 . . . . 0.0 109.546 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.592 ' CG2' ' O ' ' A' ' 23' ' ' ILE . 6.7 mm 29.75 63.12 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-O 122.01 0.91 . . . . 0.0 110.212 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.478 ' HB2' ' O ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER 165.19 -163.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.925 . . . . 0.0 109.202 -179.556 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.382 179.71 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 120.829 0.347 . . . . 0.0 110.295 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.01 -175.76 2.31 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.03 1.542 . . . . 0.0 110.397 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -103.44 146.63 16.52 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.423 ' O ' HG21 ' A' ' 4' ' ' THR . 12.3 t -103.1 44.92 0.98 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.337 -1.096 . . . . 0.0 109.78 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.541 ' O ' ' CG2' ' A' ' 5' ' ' ILE . 4.3 tp -95.59 40.51 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.239 -0.913 . . . . 0.0 109.746 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . 0.494 ' CG ' ' O ' ' A' ' 5' ' ' ILE . 20.9 mtmt -158.11 56.86 0.47 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -0.921 . . . . 0.0 109.247 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -92.09 47.71 1.36 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.32 -0.862 . . . . 0.0 109.492 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.419 ' O ' HD13 ' A' ' 9' ' ' ILE . 25.8 t-20 -88.61 43.63 1.15 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.278 -0.889 . . . . 0.0 109.51 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.445 HG23 HG13 ' A' ' 10' ' ' ILE . 2.3 mp -147.61 -54.02 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.272 -0.892 . . . . 0.0 109.183 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.445 HG13 HG23 ' A' ' 9' ' ' ILE . 13.6 mt -154.17 81.33 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -77.08 -2.85 79.87 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.508 ' O ' ' C ' ' A' ' 13' ' ' SER . 55.9 t -74.61 -93.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.096 -1.238 . . . . 0.0 109.763 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.508 ' C ' ' O ' ' A' ' 12' ' ' VAL . 0.7 OUTLIER 28.25 95.78 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 121.142 0.496 . . . . 0.0 110.987 -179.399 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.453 ' O ' ' C ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -84.67 -58.36 2.75 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.02 -1.05 . . . . 0.0 109.153 179.733 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.453 ' C ' ' O ' ' A' ' 14' ' ' TYR . 33.3 t0 40.02 40.43 0.75 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.634 -0.666 . . . . 0.0 109.774 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -173.79 -34.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.208 -0.933 . . . . 0.0 109.803 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.495 ' O ' ' N ' ' A' ' 20' ' ' ARG . 8.3 m-85 -117.79 31.68 6.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.171 -0.956 . . . . 0.0 109.468 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.479 ' C ' ' O ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER 31.87 49.41 0.12 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.217 0.532 . . . . 0.0 110.908 179.544 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.522 ' CG ' ' O ' ' A' ' 19' ' ' TYR . 11.3 t80 51.97 43.11 30.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.039 -1.038 . . . . 0.0 109.742 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.495 ' N ' ' O ' ' A' ' 17' ' ' TYR . 0.7 OUTLIER 46.88 65.46 1.22 Allowed 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.187 -0.946 . . . . 0.0 109.105 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 t -91.84 30.4 1.39 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.321 -0.862 . . . . 0.0 109.111 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 9.7 p -77.88 0.97 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.654 -0.654 . . . . 0.0 109.547 179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.2 mt -88.47 44.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.198 -0.939 . . . . 0.0 110.259 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.441 ' O ' ' HG2' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -85.46 128.58 34.78 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.074 -1.016 . . . . 0.0 109.576 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.596 179.874 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.577 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 7.8 ttt . . . . . 0 N--CA 1.492 1.652 0 N-CA-C 111.099 0.037 . . . . 0.0 111.099 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 1' ' ' MET . 48.1 Cg_endo -78.11 -178.2 4.44 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.406 1.214 . . . . 0.0 110.426 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -121.21 160.0 15.64 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.2 t -95.6 50.71 1.24 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.27 -1.135 . . . . 0.0 109.469 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.462 ' O ' ' HB2' ' A' ' 8' ' ' ASN . 7.0 mm -85.52 44.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.227 -0.92 . . . . 0.0 109.27 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.9 mttt 53.43 51.1 15.98 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.172 -0.955 . . . . 0.0 109.001 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 51.27 62.84 2.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.346 -0.846 . . . . 0.0 108.893 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.462 ' HB2' ' O ' ' A' ' 5' ' ' ILE . 19.3 t30 -98.93 38.62 1.36 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.24 -0.912 . . . . 0.0 110.245 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.446 ' O ' HD12 ' A' ' 10' ' ' ILE . 37.6 mm -78.51 -11.06 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.133 -0.979 . . . . 0.0 108.544 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.455 ' O ' ' CG2' ' A' ' 10' ' ' ILE . 33.2 mm -150.8 51.52 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -91.34 27.01 9.98 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.349 -1.101 . . . . 0.0 110.349 -178.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.485 HG13 ' N ' ' A' ' 13' ' ' SER . 1.0 OUTLIER -48.9 -48.78 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.098 -1.236 . . . . 0.0 108.884 179.54 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.485 ' N ' HG13 ' A' ' 12' ' ' VAL . 90.5 p -43.65 119.82 1.79 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.529 -0.732 . . . . 0.0 109.727 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' TYR . . . . . 0.444 ' O ' ' C ' ' A' ' 15' ' ' ASP . 0.1 OUTLIER -82.58 -30.88 29.29 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.262 -0.898 . . . . 0.0 109.516 179.851 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 14' ' ' TYR . 24.8 t70 41.94 46.61 3.57 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.446 -0.784 . . . . 0.0 109.457 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.599 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 7.8 tt0 -96.25 -51.14 4.51 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.392 -0.817 . . . . 0.0 108.858 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' TYR . . . . . 0.599 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 3.1 m-85 -177.27 32.95 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ARG . . . . . 0.487 ' C ' ' O ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER 35.75 33.55 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.651 0.739 . . . . 0.0 109.791 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' TYR . . . . . 0.493 ' N ' ' O ' ' A' ' 17' ' ' TYR . 0.2 OUTLIER 52.56 24.01 2.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.655 -0.653 . . . . 0.0 109.869 -179.934 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . 0.471 ' O ' ' C ' ' A' ' 21' ' ' SER . 29.2 tpt85 -174.14 61.41 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.048 -1.032 . . . . 0.0 110.563 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.532 ' O ' ' CG1' ' A' ' 22' ' ' VAL . 10.7 t 38.78 64.07 0.82 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.538 -0.726 . . . . 0.0 109.765 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.532 ' CG1' ' O ' ' A' ' 21' ' ' SER . 7.3 p 40.35 59.64 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 O-C-N 121.56 -0.713 . . . . 0.0 109.86 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.479 HG21 ' O ' ' A' ' 22' ' ' VAL . 8.3 tp 36.8 46.35 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.77 -0.581 . . . . 0.0 110.667 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.13 134.61 47.94 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.145 -0.972 . . . . 0.0 109.584 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.482 179.974 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.494 ' OD1' HG21 ' A' ' 12' ' ' VAL . 41.6 t-20 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.336 0.589 . . . . 0.0 109.602 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.524 HG22 ' O ' ' A' ' 9' ' ' ILE . 30.7 mm -100.27 0.98 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.38 -0.825 . . . . 0.0 109.144 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.427 ' O ' HG12 ' A' ' 10' ' ' ILE . 6.2 tt -71.83 44.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.375 -0.828 . . . . 0.0 110.923 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 53.16 79.81 0.08 OUTLIER Glycine 0 N--CA 1.489 2.189 0 O-C-N 121.063 -1.023 . . . . 0.0 110.601 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.739 HG12 ' N ' ' A' ' 13' ' ' SER . 0.9 OUTLIER -91.77 -67.29 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.252 -1.146 . . . . 0.0 108.14 178.703 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.739 ' N ' HG12 ' A' ' 12' ' ' VAL . 0.5 OUTLIER -75.15 105.15 6.02 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.712 -0.795 . . . . 0.0 108.978 179.865 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -85.89 -45.75 11.24 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.142 -0.974 . . . . 0.0 110.048 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -130.19 62.47 1.57 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.093 -1.004 . . . . 0.0 109.927 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' A' ' 17' ' ' TYR . 2.0 tt0 -155.23 17.93 0.42 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.122 -0.986 . . . . 0.0 109.757 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.46 ' HB2' ' O ' ' A' ' 16' ' ' GLU . 0.1 OUTLIER 171.76 41.94 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.239 -0.913 . . . . 0.0 109.195 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -92.78 51.27 1.68 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.394 -0.816 . . . . 0.0 109.522 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 48.48 30.03 2.26 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.289 -0.882 . . . . 0.0 109.535 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.354 0 O-C-N 121.221 -0.925 . . . . 0.0 108.991 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.405 0.621 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.576 HG22 ' O ' ' A' ' 9' ' ' ILE . 37.1 mm -84.4 2.39 3.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.382 -0.824 . . . . 0.0 108.953 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.645 HG23 ' O ' ' A' ' 10' ' ' ILE . 14.0 tt -66.11 45.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.495 -0.753 . . . . 0.0 110.635 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 9' ' ' ILE . . . 45.27 73.67 0.27 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.9 t -65.41 -61.65 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.21 -1.17 . . . . 0.0 109.052 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.1 p -73.49 70.79 1.29 Allowed 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.459 -0.897 . . . . 0.0 109.863 -178.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.07 -2.37 58.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.901 . . . . 0.0 109.747 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -154.76 55.31 0.67 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.189 -0.944 . . . . 0.0 109.51 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -161.74 -39.89 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.374 -0.829 . . . . 0.0 109.177 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -93.26 42.33 1.1 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.302 -0.874 . . . . 0.0 109.309 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.1 38.03 19.71 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.242 -0.911 . . . . 0.0 109.259 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.458 ' O ' ' C ' ' A' ' 20' ' ' ARG . 0.3 OUTLIER 66.41 6.24 4.22 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.503 -0.748 . . . . 0.0 109.933 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.483 ' O ' ' HG3' ' A' ' 20' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 121.522 0.677 . . . . 0.0 110.142 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 . . . . . 0 N--CA 1.488 1.452 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.5 mp -99.21 -19.38 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.252 -0.905 . . . . 0.0 109.076 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.593 HG23 ' O ' ' A' ' 10' ' ' ILE . 0.4 OUTLIER -120.15 29.68 2.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-O 121.759 0.79 . . . . 0.0 109.389 179.835 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.485 ' O ' ' N ' ' A' ' 13' ' ' SER . . . 64.3 4.36 12.09 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.597 HG12 ' N ' ' A' ' 13' ' ' SER . 1.2 t 67.34 -53.94 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 120.976 -1.308 . . . . 0.0 109.633 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.597 ' N ' HG12 ' A' ' 12' ' ' VAL . 0.1 OUTLIER -74.97 88.61 2.36 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.497 -0.752 . . . . 0.0 109.718 -179.08 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.51 ' CG ' ' O ' ' A' ' 14' ' ' TYR . 17.0 t80 -146.89 48.07 1.15 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.244 -0.91 . . . . 0.0 109.637 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -120.86 38.46 4.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.166 -0.959 . . . . 0.0 109.504 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -145.83 40.58 1.18 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.534 ' CB ' ' HB2' ' A' ' 20' ' ' ARG . 0.1 OUTLIER 49.28 41.38 20.13 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.511 -0.743 . . . . 0.0 109.098 -179.245 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.538 ' O ' ' CB ' ' A' ' 19' ' ' TYR . 6.2 ttt180 42.32 59.16 2.77 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.538 ' CB ' ' O ' ' A' ' 18' ' ' ARG . 22.5 t80 78.94 62.21 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -178.911 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.534 ' HB2' ' CB ' ' A' ' 17' ' ' TYR . 29.6 ttp180 . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.35 -0.844 . . . . 0.0 110.73 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.464 ' O ' HD13 ' A' ' 9' ' ' ILE . 16.7 t30 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.197 0.522 . . . . 0.0 109.799 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.496 ' O ' ' C ' ' A' ' 10' ' ' ILE . 34.6 mm -122.89 -51.97 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.248 -0.907 . . . . 0.0 109.258 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.773 HG23 ' O ' ' A' ' 10' ' ' ILE . 9.2 tp 28.29 48.64 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.986 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 153.23 97.44 0.15 Allowed Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.594 -1.288 . . . . 0.0 110.097 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.81 HG12 ' N ' ' A' ' 13' ' ' SER . 2.5 t -105.93 -83.07 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.206 -1.173 . . . . 0.0 108.989 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.81 ' N ' HG12 ' A' ' 12' ' ' VAL . 0.1 OUTLIER -68.25 92.42 0.41 Allowed 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.899 -0.721 . . . . 0.0 109.672 -179.185 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.23 47.3 2.01 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.218 -0.926 . . . . 0.0 109.387 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.453 ' CG ' ' O ' ' A' ' 15' ' ' ASP . 7.2 t70 54.2 61.61 2.96 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.105 -0.997 . . . . 0.0 108.702 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.585 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.9 OUTLIER -69.27 -33.89 73.92 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.147 -0.971 . . . . 0.0 108.944 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.585 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 96.9 m-85 -159.55 26.44 0.19 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.246 -0.909 . . . . 0.0 109.899 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.521 ' C ' ' O ' ' A' ' 17' ' ' TYR . 2.9 ttm180 27.42 43.91 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 120.976 0.417 . . . . 0.0 111.02 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.465 ' N ' ' O ' ' A' ' 17' ' ' TYR . 0.4 OUTLIER 69.66 51.41 0.46 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.031 -1.043 . . . . 0.0 109.262 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.508 ' HB3' ' HB3' ' A' ' 17' ' ' TYR . 36.4 ttp180 . . . . . 0 C--N 1.304 -1.401 0 O-C-N 121.287 -0.883 . . . . 0.0 109.121 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.952 ' C ' HD12 ' A' ' 9' ' ' ILE . 25.4 t-20 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.344 0.593 . . . . 0.0 109.715 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.952 HD12 ' C ' ' A' ' 8' ' ' ASN . 4.0 mp -147.49 -51.97 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.347 -0.846 . . . . 0.0 109.107 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.481 HG23 ' O ' ' A' ' 10' ' ' ILE . 16.5 tt 35.43 42.68 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 121.355 0.598 . . . . 0.0 109.989 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.481 ' H ' HG22 ' A' ' 9' ' ' ILE . . . -96.54 -17.61 33.06 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.829 -1.309 . . . . 0.0 109.829 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.728 HG12 ' N ' ' A' ' 13' ' ' SER . 42.9 t -68.63 -92.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.174 -1.192 . . . . 0.0 109.432 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.728 ' N ' HG12 ' A' ' 12' ' ' VAL . 15.9 p 35.61 63.59 0.53 Allowed 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.166 0.508 . . . . 0.0 110.456 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.51 -53.71 2.63 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.261 -0.899 . . . . 0.0 109.276 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -131.76 46.85 2.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.4 -0.812 . . . . 0.0 109.174 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -82.44 -29.13 30.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.299 -0.876 . . . . 0.0 109.781 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.506 ' O ' ' C ' ' A' ' 18' ' ' ARG . 0.4 OUTLIER -112.58 42.2 1.88 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.21 -0.931 . . . . 0.0 109.716 -179.736 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.506 ' C ' ' O ' ' A' ' 17' ' ' TYR . 1.8 mpp_? 31.79 52.16 0.21 Allowed 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.25 0.547 . . . . 0.0 110.631 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.415 ' O ' ' C ' ' A' ' 20' ' ' ARG . 0.2 OUTLIER 48.17 60.28 3.71 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.272 -0.892 . . . . 0.0 109.206 -179.779 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.485 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 1.7 ttm180 . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.505 -0.747 . . . . 0.0 109.637 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 63.0 t30 . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 121.285 0.564 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.723 HG23 ' HB ' ' A' ' 12' ' ' VAL . 2.0 mp -47.5 -26.64 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.144 -0.972 . . . . 0.0 108.819 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.479 HG23 ' O ' ' A' ' 10' ' ' ILE . 0.0 OUTLIER 33.31 35.76 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.371 0.605 . . . . 0.0 110.505 179.825 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.539 ' H ' HG22 ' A' ' 9' ' ' ILE . . . 95.14 100.14 1.76 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.723 ' HB ' HG23 ' A' ' 9' ' ' ILE . 2.1 t -126.48 -58.3 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.297 -1.119 . . . . 0.0 109.29 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.43 ' N ' HG12 ' A' ' 12' ' ' VAL . 1.9 p -56.58 -173.45 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.766 -178.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.99 -81.0 0.16 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.254 -0.903 . . . . 0.0 109.403 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.25 41.24 1.14 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -0.915 . . . . 0.0 109.677 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.461 ' O ' ' HB3' ' A' ' 17' ' ' TYR . 0.6 OUTLIER 54.21 18.2 1.72 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.284 -0.885 . . . . 0.0 109.793 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.461 ' HB3' ' O ' ' A' ' 16' ' ' GLU . 32.4 t80 69.02 38.97 1.86 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.144 -0.973 . . . . 0.0 109.451 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.428 ' O ' ' C ' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -88.77 42.59 1.09 Allowed 'General case' 0 C--N 1.3 -1.543 0 O-C-N 121.31 -0.869 . . . . 0.0 108.747 179.587 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.428 ' C ' ' O ' ' A' ' 18' ' ' ARG . 2.1 m-85 45.2 36.28 2.09 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.272 -0.893 . . . . 0.0 108.785 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.517 0 O-C-N 121.405 -0.81 . . . . 0.0 109.485 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 9' ' ' ILE . 30.0 t-20 . . . . . 0 N--CA 1.482 1.143 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.519 ' N ' ' OD1' ' A' ' 8' ' ' ASN . 31.2 mm -128.21 -7.55 3.8 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 O-C-N 121.464 -0.773 . . . . 0.0 109.973 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.484 HG23 ' O ' ' A' ' 10' ' ' ILE . 1.1 tt -83.06 46.31 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.133 -0.979 . . . . 0.0 109.547 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -145.66 -101.57 0.31 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.52 HG12 ' N ' ' A' ' 13' ' ' SER . 53.8 t -127.54 -84.77 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.337 -1.096 . . . . 0.0 109.634 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.52 ' N ' HG12 ' A' ' 12' ' ' VAL . 0.1 OUTLIER 56.41 118.09 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.652 0.739 . . . . 0.0 110.145 -179.57 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.564 ' CG ' ' O ' ' A' ' 14' ' ' TYR . 24.7 t80 43.34 41.13 2.95 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.544 -0.722 . . . . 0.0 110.195 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 19' ' ' TYR . 18.8 t0 40.89 63.42 1.18 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.362 -0.836 . . . . 0.0 109.767 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.72 -3.26 30.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.03 -1.044 . . . . 0.0 109.984 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.45 ' O ' ' C ' ' A' ' 18' ' ' ARG . 26.0 m-85 -124.21 39.36 3.99 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.06 -1.025 . . . . 0.0 109.777 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.469 ' O ' ' N ' ' A' ' 20' ' ' ARG . 0.5 OUTLIER 41.92 32.91 0.31 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.658 0.742 . . . . 0.0 109.297 179.938 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.531 ' N ' ' OD1' ' A' ' 15' ' ' ASP . 2.0 t80 41.05 26.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.659 -0.651 . . . . 0.0 110.028 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.495 ' C ' ' O ' ' A' ' 19' ' ' TYR . 1.2 ttp180 . . . . . 0 N--CA 1.494 1.742 0 CA-C-O 121.473 0.654 . . . . 0.0 110.104 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.756 ' C ' HD12 ' A' ' 9' ' ' ILE . 47.5 t-20 . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.223 0.535 . . . . 0.0 110.034 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.756 HD12 ' C ' ' A' ' 8' ' ' ASN . 1.6 mp -110.16 -7.69 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.276 -0.89 . . . . 0.0 109.005 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.627 HG22 ' O ' ' A' ' 9' ' ' ILE . 4.6 tt 41.94 44.76 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-O 121.575 0.702 . . . . 0.0 110.164 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -86.38 49.42 4.07 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.574 HG12 ' N ' ' A' ' 13' ' ' SER . 57.7 t -64.13 -87.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.422 -1.046 . . . . 0.0 109.98 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.574 ' N ' HG12 ' A' ' 12' ' ' VAL . 0.8 OUTLIER 43.99 95.1 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.362 0.601 . . . . 0.0 109.841 -179.27 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.592 ' CG ' ' O ' ' A' ' 14' ' ' TYR . 31.5 t80 -92.76 4.48 53.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 109.606 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.457 ' OD2' ' O ' ' A' ' 15' ' ' ASP . 6.6 t70 54.75 72.3 0.48 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.073 -1.017 . . . . 0.0 109.345 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.16 -13.86 37.43 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.525 ' O ' ' N ' ' A' ' 19' ' ' TYR . 16.0 t80 -123.49 69.01 1.02 Allowed 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 178.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.8 ttp85 -62.1 39.21 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.731 -0.606 . . . . 0.0 111.432 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.525 ' N ' ' O ' ' A' ' 17' ' ' TYR . 10.1 t80 -144.59 10.42 1.41 Allowed 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.59 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.454 ' O ' ' CG ' ' A' ' 20' ' ' ARG . 6.4 ttm180 . . . . . 0 N--CA 1.482 1.146 0 O-C-N 121.114 -0.991 . . . . 0.0 108.91 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.655 ' C ' HD12 ' A' ' 9' ' ' ILE . 39.1 t30 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.059 0.457 . . . . 0.0 109.92 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.856 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.3 mp -123.77 -31.14 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.039 -1.038 . . . . 0.0 109.881 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.516 ' C ' ' O ' ' A' ' 9' ' ' ILE . 0.6 OUTLIER 29.29 45.63 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 121.187 0.518 . . . . 0.0 110.66 179.773 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 9' ' ' ILE . . . -121.02 47.94 0.99 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.485 ' O ' ' N ' ' A' ' 14' ' ' TYR . 0.6 OUTLIER -81.91 -33.22 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.291 -1.123 . . . . 0.0 109.2 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 12' ' ' VAL . 7.4 m -42.41 97.08 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.936 -178.553 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.485 ' N ' ' O ' ' A' ' 12' ' ' VAL . 0.6 OUTLIER -121.58 -47.04 2.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.322 -0.861 . . . . 0.0 109.262 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.58 49.67 0.82 Allowed 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.263 -0.898 . . . . 0.0 109.098 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -48.36 -22.98 0.79 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.274 -0.891 . . . . 0.0 109.359 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.43 ' O ' ' C ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -114.86 37.55 3.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.202 -0.936 . . . . 0.0 109.304 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.43 ' C ' ' O ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER 39.75 33.07 0.12 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.569 -0.707 . . . . 0.0 110.094 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.471 ' O ' ' C ' ' A' ' 20' ' ' ARG . 0.4 OUTLIER 69.35 0.53 2.92 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.418 -0.801 . . . . 0.0 110.786 179.332 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.5 ' O ' ' HG3' ' A' ' 20' ' ' ARG . 2.5 tpm_? . . . . . 0 N--CA 1.489 1.482 0 O-C-N 121.365 -0.834 . . . . 0.0 109.615 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 121.376 0.608 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.602 ' O ' HG22 ' A' ' 10' ' ' ILE . 8.9 mm -78.27 -3.09 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.285 -0.884 . . . . 0.0 109.651 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.771 HG23 ' O ' ' A' ' 10' ' ' ILE . 0.3 OUTLIER 56.36 33.1 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-O 122.071 0.939 . . . . 0.0 109.708 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -151.78 -40.44 0.03 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.468 ' O ' ' O ' ' A' ' 13' ' ' SER . 0.5 OUTLIER -96.23 -19.56 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.425 -1.044 . . . . 0.0 108.821 179.568 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 12' ' ' VAL . 0.2 OUTLIER -54.4 -168.07 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.084 -178.29 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -114.93 5.13 14.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.331 -0.855 . . . . 0.0 109.8 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.72 52.91 0.74 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.083 -1.01 . . . . 0.0 109.636 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.473 ' OE1' HG13 ' A' ' 10' ' ' ILE . 20.2 tt0 -163.32 -55.51 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.226 -0.921 . . . . 0.0 109.555 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.516 ' O ' ' N ' ' A' ' 20' ' ' ARG . 0.3 OUTLIER -129.22 21.78 5.69 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.111 -0.993 . . . . 0.0 109.678 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.504 ' C ' ' O ' ' A' ' 17' ' ' TYR . 0.4 OUTLIER 30.66 42.47 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.139 0.495 . . . . 0.0 110.708 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.492 ' CD2' ' O ' ' A' ' 19' ' ' TYR . 71.2 t80 52.69 43.59 31.13 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.182 -0.949 . . . . 0.0 109.521 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.518 ' O ' ' CG ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.401 0 O-C-N 121.396 -0.815 . . . . 0.0 109.677 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.465 ' C ' HD12 ' A' ' 9' ' ' ILE . 20.0 t-20 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.309 0.576 . . . . 0.0 109.909 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.762 HG22 HD12 ' A' ' 10' ' ' ILE . 4.2 mp -130.35 -64.43 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-O 121.877 0.846 . . . . 0.0 109.197 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.775 HG22 ' O ' ' A' ' 10' ' ' ILE . 0.9 OUTLIER -159.0 82.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.873 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 178.66 92.11 0.08 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.472 ' O ' ' O ' ' A' ' 13' ' ' SER . 87.9 t -95.29 -62.31 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.316 -1.108 . . . . 0.0 109.722 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.472 ' O ' ' O ' ' A' ' 12' ' ' VAL . 1.9 p -48.25 177.07 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.788 -178.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.44 ' O ' ' CD2' ' A' ' 14' ' ' TYR . 61.3 t80 -98.47 -1.51 41.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.33 -0.856 . . . . 0.0 109.664 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -108.86 29.24 7.65 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.235 -0.916 . . . . 0.0 109.665 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 58.75 9.7 1.24 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.548 -0.72 . . . . 0.0 110.864 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER 63.44 45.59 4.75 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 120.703 -1.248 . . . . 0.0 108.82 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.524 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -79.5 48.58 0.92 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.931 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.524 ' HB2' ' O ' ' A' ' 18' ' ' ARG . 0.5 OUTLIER 73.14 44.84 0.31 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.727 -0.608 . . . . 0.0 109.489 -179.426 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.453 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.405 0 O-C-N 121.343 -0.848 . . . . 0.0 108.851 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.729 ' C ' HD12 ' A' ' 9' ' ' ILE . 25.8 t-20 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.331 0.586 . . . . 0.0 109.51 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.729 HD12 ' C ' ' A' ' 8' ' ' ASN . 2.3 mp -147.61 -54.02 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.272 -0.892 . . . . 0.0 109.183 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.627 HG13 HG22 ' A' ' 9' ' ' ILE . 13.6 mt -154.17 81.33 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -77.08 -2.85 79.87 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.696 HG12 ' N ' ' A' ' 13' ' ' SER . 55.9 t -74.61 -93.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.096 -1.238 . . . . 0.0 109.763 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.696 ' N ' HG12 ' A' ' 12' ' ' VAL . 0.7 OUTLIER 28.25 95.78 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 121.142 0.496 . . . . 0.0 110.987 -179.399 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.453 ' O ' ' C ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -84.67 -58.36 2.75 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.02 -1.05 . . . . 0.0 109.153 179.733 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.453 ' C ' ' O ' ' A' ' 14' ' ' TYR . 33.3 t0 40.02 40.43 0.75 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.634 -0.666 . . . . 0.0 109.774 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -173.79 -34.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.208 -0.933 . . . . 0.0 109.803 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.495 ' O ' ' N ' ' A' ' 20' ' ' ARG . 8.3 m-85 -117.79 31.68 6.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.171 -0.956 . . . . 0.0 109.468 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.479 ' C ' ' O ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER 31.87 49.41 0.12 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.217 0.532 . . . . 0.0 110.908 179.544 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.522 ' O ' ' CG ' ' A' ' 19' ' ' TYR . 11.3 t80 51.97 43.11 30.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.039 -1.038 . . . . 0.0 109.742 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.495 ' N ' ' O ' ' A' ' 17' ' ' TYR . 0.7 OUTLIER . . . . . 0 C--N 1.306 -1.298 0 O-C-N 121.187 -0.946 . . . . 0.0 109.105 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 19.3 t30 . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 121.257 0.551 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.409 ' C ' HG12 ' A' ' 10' ' ' ILE . 37.6 mm -78.51 -11.06 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.133 -0.979 . . . . 0.0 108.544 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.702 HG22 ' O ' ' A' ' 10' ' ' ILE . 33.2 mm -150.8 51.52 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -91.34 27.01 9.98 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.349 -1.101 . . . . 0.0 110.349 -178.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.493 HG12 ' N ' ' A' ' 13' ' ' SER . 1.0 OUTLIER -48.9 -48.78 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.098 -1.236 . . . . 0.0 108.884 179.54 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.493 ' N ' HG12 ' A' ' 12' ' ' VAL . 90.5 p -43.65 119.82 1.79 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.529 -0.732 . . . . 0.0 109.727 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' TYR . . . . . 0.444 ' O ' ' C ' ' A' ' 15' ' ' ASP . 0.1 OUTLIER -82.58 -30.88 29.29 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.262 -0.898 . . . . 0.0 109.516 179.851 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 15' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 14' ' ' TYR . 24.8 t70 41.94 46.61 3.57 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.446 -0.784 . . . . 0.0 109.457 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.599 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 7.8 tt0 -96.25 -51.14 4.51 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.392 -0.817 . . . . 0.0 108.858 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' TYR . . . . . 0.599 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 3.1 m-85 -177.27 32.95 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ARG . . . . . 0.487 ' C ' ' O ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER 35.75 33.55 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.651 0.739 . . . . 0.0 109.791 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 19' ' ' TYR . . . . . 0.493 ' N ' ' O ' ' A' ' 17' ' ' TYR . 0.2 OUTLIER 52.56 24.01 2.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.655 -0.653 . . . . 0.0 109.869 -179.934 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ARG . . . . . 0.436 ' HA ' ' HD2' ' A' ' 20' ' ' ARG . 29.2 tpt85 . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.048 -1.032 . . . . 0.0 110.563 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 120.677 0.275 . . . . 0.0 110.267 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -75.4 164.2 33.07 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.927 1.488 . . . . 0.0 110.333 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 92.52 -23.85 25.98 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.803 ' O ' HG23 ' A' ' 4' ' ' THR . 7.1 t -119.69 58.26 0.89 Allowed 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.464 -1.021 . . . . 0.0 109.829 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.809 HG23 ' O ' ' A' ' 5' ' ' ILE . 1.1 tp -80.03 48.43 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.141 -0.975 . . . . 0.0 109.476 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -152.82 35.0 0.48 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.196 -0.94 . . . . 0.0 108.911 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -169.16 70.64 0.07 Allowed 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.494 ' OD1' HG21 ' A' ' 12' ' ' VAL . 41.6 t-20 -80.99 45.62 0.84 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.508 -0.745 . . . . 0.0 109.602 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.524 HG22 ' O ' ' A' ' 9' ' ' ILE . 30.7 mm -100.27 0.98 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.38 -0.825 . . . . 0.0 109.144 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.427 ' O ' HG12 ' A' ' 10' ' ' ILE . 6.2 tt -71.83 44.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.375 -0.828 . . . . 0.0 110.923 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 53.16 79.81 0.08 OUTLIER Glycine 0 N--CA 1.489 2.189 0 O-C-N 121.063 -1.023 . . . . 0.0 110.601 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.739 HG12 ' N ' ' A' ' 13' ' ' SER . 0.9 OUTLIER -91.77 -67.29 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.252 -1.146 . . . . 0.0 108.14 178.703 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.739 ' N ' HG12 ' A' ' 12' ' ' VAL . 0.5 OUTLIER -75.15 105.15 6.02 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.712 -0.795 . . . . 0.0 108.978 179.865 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -85.89 -45.75 11.24 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.142 -0.974 . . . . 0.0 110.048 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -130.19 62.47 1.57 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.093 -1.004 . . . . 0.0 109.927 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' A' ' 17' ' ' TYR . 2.0 tt0 -155.23 17.93 0.42 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.122 -0.986 . . . . 0.0 109.757 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.46 ' HB2' ' O ' ' A' ' 16' ' ' GLU . 0.1 OUTLIER 171.76 41.94 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.239 -0.913 . . . . 0.0 109.195 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -92.78 51.27 1.68 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.394 -0.816 . . . . 0.0 109.522 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 48.48 30.03 2.26 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.289 -0.882 . . . . 0.0 109.535 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.44 39.38 1.83 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.221 -0.925 . . . . 0.0 108.991 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.61 31.65 5.28 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.492 -0.755 . . . . 0.0 109.124 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.597 HG13 HG13 ' A' ' 23' ' ' ILE . 14.7 p -92.84 -0.96 10.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.64 -0.663 . . . . 0.0 109.39 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.597 HG13 HG13 ' A' ' 22' ' ' VAL . 1.5 mp -122.52 42.2 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.187 -0.946 . . . . 0.0 109.377 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.4 161.03 0.13 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.309 -0.869 . . . . 0.0 109.603 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 118.047 -0.978 . . . . 0.0 109.406 179.962 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.546 ' N ' ' HD2' ' A' ' 2' ' ' PRO . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.791 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 1' ' ' MET . 43.7 Cg_endo -72.18 -163.67 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.741 1.39 . . . . 0.0 110.366 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -109.06 5.69 32.21 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.535 ' O ' HG23 ' A' ' 4' ' ' THR . 15.2 t -86.1 43.65 1.07 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.204 -1.174 . . . . 0.0 109.729 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.9 mm -110.02 44.6 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.174 -0.954 . . . . 0.0 109.159 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 179.29 51.26 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -96.3 58.41 1.79 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.537 -0.727 . . . . 0.0 109.073 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -76.45 47.71 0.49 Allowed 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.595 -0.691 . . . . 0.0 109.452 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.576 HG22 ' O ' ' A' ' 9' ' ' ILE . 37.1 mm -84.4 2.39 3.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.382 -0.824 . . . . 0.0 108.953 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.645 HG23 ' O ' ' A' ' 10' ' ' ILE . 14.0 tt -66.11 45.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.495 -0.753 . . . . 0.0 110.635 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 9' ' ' ILE . . . 45.27 73.67 0.27 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.9 t -65.41 -61.65 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.21 -1.17 . . . . 0.0 109.052 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.1 p -73.49 70.79 1.29 Allowed 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.459 -0.897 . . . . 0.0 109.863 -178.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.07 -2.37 58.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.901 . . . . 0.0 109.747 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -154.76 55.31 0.67 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.189 -0.944 . . . . 0.0 109.51 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -161.74 -39.89 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.374 -0.829 . . . . 0.0 109.177 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -93.26 42.33 1.1 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.302 -0.874 . . . . 0.0 109.309 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.1 38.03 19.71 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.242 -0.911 . . . . 0.0 109.259 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.458 ' O ' ' C ' ' A' ' 20' ' ' ARG . 0.3 OUTLIER 66.41 6.24 4.22 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.503 -0.748 . . . . 0.0 109.933 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.483 ' O ' ' HG3' ' A' ' 20' ' ' ARG . 0.2 OUTLIER 35.33 40.41 0.07 Allowed 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 121.522 0.677 . . . . 0.0 110.142 179.634 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.7 p -105.12 37.45 2.18 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.209 -0.932 . . . . 0.0 108.932 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.645 ' O ' HG22 ' A' ' 22' ' ' VAL . 3.7 p -83.36 0.63 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.524 -0.735 . . . . 0.0 110.172 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.533 ' O ' ' CB ' ' A' ' 24' ' ' LYS . 11.2 mm -94.8 32.85 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.966 -1.084 . . . . 0.0 109.615 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.533 ' CB ' ' O ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER 158.37 56.4 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.649 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.457 -179.932 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.558 ' HB3' ' HD3' ' A' ' 2' ' ' PRO . 2.0 tpp . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 110.671 -0.122 . . . . 0.0 110.671 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.558 ' HD3' ' HB3' ' A' ' 1' ' ' MET . 47.5 Cg_endo -74.54 105.2 2.01 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.365 1.192 . . . . 0.0 110.377 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -157.58 166.58 33.86 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.834 -1.307 . . . . 0.0 109.834 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.0 t -89.89 40.21 0.99 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.344 -1.092 . . . . 0.0 109.55 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.657 HG22 ' O ' ' A' ' 5' ' ' ILE . 13.4 mt -112.23 40.8 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.245 -0.909 . . . . 0.0 109.335 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.07 49.11 1.05 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.479 -0.763 . . . . 0.0 109.184 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 50.38 62.6 2.6 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.356 -0.84 . . . . 0.0 109.406 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -117.48 46.21 1.76 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.269 -0.895 . . . . 0.0 109.536 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.5 mp -99.21 -19.38 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.252 -0.905 . . . . 0.0 109.076 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.593 HG23 ' O ' ' A' ' 10' ' ' ILE . 0.4 OUTLIER -120.15 29.68 2.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-O 121.759 0.79 . . . . 0.0 109.389 179.835 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.485 ' O ' ' N ' ' A' ' 13' ' ' SER . . . 64.3 4.36 12.09 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.597 HG12 ' N ' ' A' ' 13' ' ' SER . 1.2 t 67.34 -53.94 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 120.976 -1.308 . . . . 0.0 109.633 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.597 ' N ' HG12 ' A' ' 12' ' ' VAL . 0.1 OUTLIER -74.97 88.61 2.36 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.497 -0.752 . . . . 0.0 109.718 -179.08 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.51 ' CG ' ' O ' ' A' ' 14' ' ' TYR . 17.0 t80 -146.89 48.07 1.15 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.244 -0.91 . . . . 0.0 109.637 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -120.86 38.46 4.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.166 -0.959 . . . . 0.0 109.504 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -145.83 40.58 1.18 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.534 ' CB ' ' HB2' ' A' ' 20' ' ' ARG . 0.1 OUTLIER 49.28 41.38 20.13 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.511 -0.743 . . . . 0.0 109.098 -179.245 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.538 ' O ' ' CB ' ' A' ' 19' ' ' TYR . 6.2 ttt180 42.32 59.16 2.77 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.538 ' CB ' ' O ' ' A' ' 18' ' ' ARG . 22.5 t80 78.94 62.21 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -178.911 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.534 ' HB2' ' CB ' ' A' ' 17' ' ' TYR . 29.6 ttp180 -70.0 39.99 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.35 -0.844 . . . . 0.0 110.73 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.424 ' H ' ' C ' ' A' ' 19' ' ' TYR . 0.9 OUTLIER -117.38 22.61 12.34 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.659 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.5 t -135.81 -28.04 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.141 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.0 mp -118.1 54.99 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 121.252 -0.905 . . . . 0.0 109.284 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.1 tttt -85.59 56.73 4.09 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.29 -0.882 . . . . 0.0 109.587 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.508 179.862 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.0 mtm . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 120.783 0.325 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -73.91 171.84 17.08 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.054 1.555 . . . . 0.0 110.423 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -105.06 -118.28 4.45 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.531 ' O ' ' C ' ' A' ' 5' ' ' ILE . 13.9 t -106.06 34.62 3.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.212 -1.169 . . . . 0.0 109.491 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.852 HG22 ' O ' ' A' ' 5' ' ' ILE . 2.8 mp 23.66 58.08 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 CA-C-O 121.845 0.831 . . . . 0.0 110.839 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' ' 7' ' ' GLU . 12.6 mttt 44.64 45.28 7.93 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.24 -0.913 . . . . 0.0 110.279 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 4' ' ' THR . 29.0 mt-10 41.17 56.58 3.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.303 -0.873 . . . . 0.0 110.053 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.464 ' O ' HD13 ' A' ' 9' ' ' ILE . 16.7 t30 -115.49 43.39 2.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.107 -0.996 . . . . 0.0 109.799 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.496 ' O ' ' C ' ' A' ' 10' ' ' ILE . 34.6 mm -122.89 -51.97 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.248 -0.907 . . . . 0.0 109.258 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.773 ' O ' HG23 ' A' ' 10' ' ' ILE . 9.2 tp 28.29 48.64 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.986 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 153.23 97.44 0.15 Allowed Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.594 -1.288 . . . . 0.0 110.097 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.81 HG12 ' N ' ' A' ' 13' ' ' SER . 2.5 t -105.93 -83.07 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.206 -1.173 . . . . 0.0 108.989 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.81 ' N ' HG12 ' A' ' 12' ' ' VAL . 0.1 OUTLIER -68.25 92.42 0.41 Allowed 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.899 -0.721 . . . . 0.0 109.672 -179.185 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.23 47.3 2.01 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.218 -0.926 . . . . 0.0 109.387 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.453 ' CG ' ' O ' ' A' ' 15' ' ' ASP . 7.2 t70 54.2 61.61 2.96 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.105 -0.997 . . . . 0.0 108.702 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.585 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.9 OUTLIER -69.27 -33.89 73.92 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.147 -0.971 . . . . 0.0 108.944 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.585 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 96.9 m-85 -159.55 26.44 0.19 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.246 -0.909 . . . . 0.0 109.899 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.521 ' C ' ' O ' ' A' ' 17' ' ' TYR . 2.9 ttm180 27.42 43.91 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 120.976 0.417 . . . . 0.0 111.02 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.465 ' N ' ' O ' ' A' ' 17' ' ' TYR . 0.4 OUTLIER 69.66 51.41 0.46 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.031 -1.043 . . . . 0.0 109.262 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.508 ' HB3' ' HB3' ' A' ' 17' ' ' TYR . 36.4 ttp180 -90.82 40.24 1.01 Allowed 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.287 -0.883 . . . . 0.0 109.121 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -89.3 34.55 0.8 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.403 -0.81 . . . . 0.0 108.926 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.507 ' O ' HG12 ' A' ' 22' ' ' VAL . 46.3 t -130.65 59.41 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.51 -0.744 . . . . 0.0 109.685 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.821 HG22 ' O ' ' A' ' 23' ' ' ILE . 0.9 OUTLIER 37.38 73.52 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 CA-C-O 122.057 0.932 . . . . 0.0 109.942 179.182 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.472 ' O ' ' O ' ' A' ' 23' ' ' ILE . 10.2 mttp 43.39 99.54 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.415 -0.803 . . . . 0.0 110.586 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.097 -1.002 . . . . 0.0 109.173 179.38 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.548 ' HB3' ' HD3' ' A' ' 2' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.759 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.548 ' HD3' ' HB3' ' A' ' 1' ' ' MET . 44.0 Cg_endo -69.93 123.27 9.89 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.613 1.322 . . . . 0.0 110.468 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -89.14 -165.01 40.81 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.457 ' O ' ' C ' ' A' ' 5' ' ' ILE . 4.2 t -88.42 38.87 0.88 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.247 -1.149 . . . . 0.0 109.652 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.557 HG23 ' O ' ' A' ' 5' ' ' ILE . 8.1 tp 35.27 44.25 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.853 -0.529 . . . . 0.0 110.761 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.516 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 4.1 tptp -151.04 19.07 0.77 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.947 -1.095 . . . . 0.0 109.943 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.516 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 1.3 tt0 169.36 68.6 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.952 ' C ' HD12 ' A' ' 9' ' ' ILE . 25.4 t-20 -111.73 40.37 2.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.132 -0.98 . . . . 0.0 109.715 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.952 HD12 ' C ' ' A' ' 8' ' ' ASN . 4.0 mp -147.49 -51.97 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.347 -0.846 . . . . 0.0 109.107 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.481 ' O ' HG23 ' A' ' 10' ' ' ILE . 16.5 tt 35.43 42.68 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 121.355 0.598 . . . . 0.0 109.989 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.481 ' H ' HG22 ' A' ' 9' ' ' ILE . . . -96.54 -17.61 33.06 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.829 -1.309 . . . . 0.0 109.829 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.728 HG12 ' N ' ' A' ' 13' ' ' SER . 42.9 t -68.63 -92.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.174 -1.192 . . . . 0.0 109.432 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.728 ' N ' HG12 ' A' ' 12' ' ' VAL . 15.9 p 35.61 63.59 0.53 Allowed 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.166 0.508 . . . . 0.0 110.456 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.51 -53.71 2.63 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.261 -0.899 . . . . 0.0 109.276 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -131.76 46.85 2.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.4 -0.812 . . . . 0.0 109.174 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -82.44 -29.13 30.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.299 -0.876 . . . . 0.0 109.781 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.506 ' O ' ' C ' ' A' ' 18' ' ' ARG . 0.4 OUTLIER -112.58 42.2 1.88 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.21 -0.931 . . . . 0.0 109.716 -179.736 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.506 ' C ' ' O ' ' A' ' 17' ' ' TYR . 1.8 mpp_? 31.79 52.16 0.21 Allowed 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.25 0.547 . . . . 0.0 110.631 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.415 ' O ' ' C ' ' A' ' 20' ' ' ARG . 0.2 OUTLIER 48.17 60.28 3.71 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.272 -0.892 . . . . 0.0 109.206 -179.779 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.485 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 1.7 ttm180 41.45 50.96 3.71 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.505 -0.747 . . . . 0.0 109.637 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.449 ' C ' ' O ' ' A' ' 20' ' ' ARG . 74.3 m 39.39 54.44 2.31 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.529 -0.732 . . . . 0.0 110.243 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.787 ' O ' HG12 ' A' ' 22' ' ' VAL . 78.3 t -110.29 44.89 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.238 -0.914 . . . . 0.0 109.07 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.429 ' O ' ' C ' ' A' ' 24' ' ' LYS . 3.4 mp -131.48 64.57 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.235 -0.916 . . . . 0.0 109.242 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 23' ' ' ILE . 21.2 ttpt -43.16 150.96 0.16 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.411 -0.806 . . . . 0.0 109.557 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.464 -179.949 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 120.839 0.352 . . . . 0.0 110.167 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.72 79.5 2.23 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.982 1.517 . . . . 0.0 110.38 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -99.1 -177.77 31.79 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.761 ' O ' HG23 ' A' ' 4' ' ' THR . 4.7 t -117.74 44.42 2.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.172 -1.193 . . . . 0.0 109.871 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.762 HG22 ' O ' ' A' ' 5' ' ' ILE . 65.6 mt -128.51 67.78 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.143 -0.973 . . . . 0.0 109.767 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.99 39.98 3.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.382 -0.824 . . . . 0.0 108.957 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -126.96 42.0 3.41 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -98.78 43.81 1.05 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.455 -0.778 . . . . 0.0 109.588 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.723 HG23 ' HB ' ' A' ' 12' ' ' VAL . 2.0 mp -47.5 -26.64 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.144 -0.972 . . . . 0.0 108.819 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.479 ' O ' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER 33.31 35.76 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.371 0.605 . . . . 0.0 110.505 179.825 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.539 ' H ' HG22 ' A' ' 9' ' ' ILE . . . 95.14 100.14 1.76 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.723 ' HB ' HG23 ' A' ' 9' ' ' ILE . 2.1 t -126.48 -58.3 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.297 -1.119 . . . . 0.0 109.29 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.43 ' N ' HG12 ' A' ' 12' ' ' VAL . 1.9 p -56.58 -173.45 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.766 -178.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.99 -81.0 0.16 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.254 -0.903 . . . . 0.0 109.403 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.25 41.24 1.14 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -0.915 . . . . 0.0 109.677 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.461 ' O ' ' HB3' ' A' ' 17' ' ' TYR . 0.6 OUTLIER 54.21 18.2 1.72 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.284 -0.885 . . . . 0.0 109.793 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.461 ' HB3' ' O ' ' A' ' 16' ' ' GLU . 32.4 t80 69.02 38.97 1.86 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.144 -0.973 . . . . 0.0 109.451 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.428 ' O ' ' C ' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -88.77 42.59 1.09 Allowed 'General case' 0 C--N 1.3 -1.543 0 O-C-N 121.31 -0.869 . . . . 0.0 108.747 179.587 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.428 ' C ' ' O ' ' A' ' 18' ' ' ARG . 2.1 m-85 45.2 36.28 2.09 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.272 -0.893 . . . . 0.0 108.785 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.9 37.48 0.97 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.405 -0.81 . . . . 0.0 109.485 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.4 m -144.2 28.8 1.34 Allowed 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.806 0.812 . . . . 0.0 108.86 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.823 ' O ' HG13 ' A' ' 22' ' ' VAL . 9.9 p -119.35 62.77 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-O 121.533 0.683 . . . . 0.0 109.401 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.831 ' O ' HG23 ' A' ' 23' ' ' ILE . 3.7 tp -76.59 41.89 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.075 -1.016 . . . . 0.0 110.708 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 23' ' ' ILE . 15.9 mtpt 62.53 73.22 0.47 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.662 -1.274 . . . . 0.0 109.308 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 117.933 -1.032 . . . . 0.0 109.477 -179.85 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.2 178.01 7.11 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.099 1.579 . . . . 0.0 110.337 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 133.96 -4.54 4.63 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.439 ' O ' HD13 ' A' ' 5' ' ' ILE . 7.1 t -89.71 41.13 1.03 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.192 -1.181 . . . . 0.0 109.291 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.439 HD13 ' O ' ' A' ' 4' ' ' THR . 19.4 mm -141.13 64.18 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.382 -0.824 . . . . 0.0 109.236 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.489 ' O ' ' CB ' ' A' ' 7' ' ' GLU . 0.3 OUTLIER -169.96 87.74 0.14 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.332 -0.855 . . . . 0.0 109.048 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.489 ' CB ' ' O ' ' A' ' 6' ' ' LYS . 17.4 mt-10 76.35 95.2 0.07 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.402 -0.811 . . . . 0.0 109.172 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 9' ' ' ILE . 30.0 t-20 -99.82 -111.79 0.18 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.438 -0.789 . . . . 0.0 109.03 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.519 ' N ' ' OD1' ' A' ' 8' ' ' ASN . 31.2 mm -128.21 -7.55 3.8 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 O-C-N 121.464 -0.773 . . . . 0.0 109.973 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.484 ' O ' HG23 ' A' ' 10' ' ' ILE . 1.1 tt -83.06 46.31 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.133 -0.979 . . . . 0.0 109.547 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -145.66 -101.57 0.31 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.52 HG12 ' N ' ' A' ' 13' ' ' SER . 53.8 t -127.54 -84.77 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.337 -1.096 . . . . 0.0 109.634 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.52 ' N ' HG12 ' A' ' 12' ' ' VAL . 0.1 OUTLIER 56.41 118.09 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.652 0.739 . . . . 0.0 110.145 -179.57 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.564 ' CG ' ' O ' ' A' ' 14' ' ' TYR . 24.7 t80 43.34 41.13 2.95 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.544 -0.722 . . . . 0.0 110.195 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 19' ' ' TYR . 18.8 t0 40.89 63.42 1.18 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.362 -0.836 . . . . 0.0 109.767 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.72 -3.26 30.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.03 -1.044 . . . . 0.0 109.984 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.45 ' O ' ' C ' ' A' ' 18' ' ' ARG . 26.0 m-85 -124.21 39.36 3.99 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.06 -1.025 . . . . 0.0 109.777 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.61 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.5 OUTLIER 41.92 32.91 0.31 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.658 0.742 . . . . 0.0 109.297 179.938 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.531 ' N ' ' OD1' ' A' ' 15' ' ' ASP . 2.0 t80 41.05 26.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.659 -0.651 . . . . 0.0 110.028 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.512 ' O ' ' HB2' ' A' ' 21' ' ' SER . 1.2 ttp180 33.07 40.18 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.473 0.654 . . . . 0.0 110.104 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.512 ' HB2' ' O ' ' A' ' 20' ' ' ARG . 25.8 t 168.13 52.85 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.468 -0.77 . . . . 0.0 109.409 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.675 ' O ' HG12 ' A' ' 22' ' ' VAL . 96.9 t -112.46 59.86 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.096 -1.002 . . . . 0.0 109.57 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.674 HD12 ' N ' ' A' ' 23' ' ' ILE . 4.5 mp -134.73 61.08 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.362 -0.836 . . . . 0.0 109.459 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' A' ' 24' ' ' LYS . 8.0 tptp 48.72 82.26 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.222 -0.924 . . . . 0.0 109.409 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.4 ' O ' ' O ' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.488 1.456 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.524 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mtt . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -74.69 78.27 2.83 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.96 1.505 . . . . 0.0 110.229 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -164.44 169.16 39.12 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.608 ' O ' HG23 ' A' ' 4' ' ' THR . 14.8 t -86.12 47.7 1.5 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.264 -1.139 . . . . 0.0 109.432 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.549 HD13 ' C ' ' A' ' 4' ' ' THR . 4.0 mm -106.59 56.63 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.302 -0.874 . . . . 0.0 109.566 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 5' ' ' ILE . 0.1 OUTLIER -146.28 71.42 1.25 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.276 -0.89 . . . . 0.0 109.196 179.988 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -86.58 50.57 2.03 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.43 -0.794 . . . . 0.0 109.128 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.756 ' C ' HD12 ' A' ' 9' ' ' ILE . 47.5 t-20 -81.09 43.76 0.73 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.322 -0.861 . . . . 0.0 110.034 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.756 HD12 ' C ' ' A' ' 8' ' ' ASN . 1.6 mp -110.16 -7.69 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.276 -0.89 . . . . 0.0 109.005 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.627 HG22 ' O ' ' A' ' 9' ' ' ILE . 4.6 tt 41.94 44.76 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-O 121.575 0.702 . . . . 0.0 110.164 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -86.38 49.42 4.07 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.574 HG12 ' N ' ' A' ' 13' ' ' SER . 57.7 t -64.13 -87.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.422 -1.046 . . . . 0.0 109.98 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.574 ' N ' HG12 ' A' ' 12' ' ' VAL . 0.8 OUTLIER 43.99 95.1 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.362 0.601 . . . . 0.0 109.841 -179.27 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.592 ' CG ' ' O ' ' A' ' 14' ' ' TYR . 31.5 t80 -92.76 4.48 53.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 109.606 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.457 ' O ' ' OD2' ' A' ' 15' ' ' ASP . 6.6 t70 54.75 72.3 0.48 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.073 -1.017 . . . . 0.0 109.345 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.16 -13.86 37.43 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.525 ' O ' ' N ' ' A' ' 19' ' ' TYR . 16.0 t80 -123.49 69.01 1.02 Allowed 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 178.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.8 ttp85 -62.1 39.21 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.731 -0.606 . . . . 0.0 111.432 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.525 ' N ' ' O ' ' A' ' 17' ' ' TYR . 10.1 t80 -144.59 10.42 1.41 Allowed 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.59 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.454 ' CG ' ' O ' ' A' ' 20' ' ' ARG . 6.4 ttm180 -79.55 50.01 1.08 Allowed 'General case' 0 N--CA 1.482 1.146 0 O-C-N 121.114 -0.991 . . . . 0.0 108.91 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.1 t -78.65 45.39 0.58 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.124 -0.985 . . . . 0.0 109.011 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.678 ' O ' HG12 ' A' ' 22' ' ' VAL . 62.9 t -81.33 11.5 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.285 -0.884 . . . . 0.0 109.859 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.778 ' H ' HD12 ' A' ' 23' ' ' ILE . 3.7 mp -84.29 44.44 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.115 -0.99 . . . . 0.0 109.599 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.0 mtpt -147.99 -179.98 7.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.287 -0.883 . . . . 0.0 109.221 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.515 -179.906 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.524 ' CB ' ' HD3' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.757 0 CA-C-O 120.809 0.338 . . . . 0.0 110.171 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.524 ' HD3' ' CB ' ' A' ' 1' ' ' MET . 47.3 Cg_endo -74.07 161.66 40.51 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.962 1.506 . . . . 0.0 110.58 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -136.15 -120.46 1.98 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.476 ' N ' HD12 ' A' ' 5' ' ' ILE . 8.8 t -95.83 42.48 1.09 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.251 -1.147 . . . . 0.0 109.413 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.608 ' N ' HD12 ' A' ' 5' ' ' ILE . 3.3 mp -131.63 68.74 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.238 -0.914 . . . . 0.0 109.415 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -124.14 56.89 1.24 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.248 -0.908 . . . . 0.0 109.608 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 49.28 63.59 2.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.224 -0.923 . . . . 0.0 109.546 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.655 ' C ' HD12 ' A' ' 9' ' ' ILE . 39.1 t30 -113.0 46.23 1.25 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.238 -0.914 . . . . 0.0 109.92 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.856 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.3 mp -123.77 -31.14 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.039 -1.038 . . . . 0.0 109.881 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.516 ' C ' ' O ' ' A' ' 9' ' ' ILE . 0.6 OUTLIER 29.29 45.63 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 121.187 0.518 . . . . 0.0 110.66 179.773 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 9' ' ' ILE . . . -121.02 47.94 0.99 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.485 ' O ' ' N ' ' A' ' 14' ' ' TYR . 0.6 OUTLIER -81.91 -33.22 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.291 -1.123 . . . . 0.0 109.2 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 12' ' ' VAL . 7.4 m -42.41 97.08 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.936 -178.553 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.485 ' N ' ' O ' ' A' ' 12' ' ' VAL . 0.6 OUTLIER -121.58 -47.04 2.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.322 -0.861 . . . . 0.0 109.262 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.58 49.67 0.82 Allowed 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.263 -0.898 . . . . 0.0 109.098 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -48.36 -22.98 0.79 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.274 -0.891 . . . . 0.0 109.359 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.43 ' O ' ' C ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -114.86 37.55 3.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.202 -0.936 . . . . 0.0 109.304 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.43 ' C ' ' O ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER 39.75 33.07 0.12 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.569 -0.707 . . . . 0.0 110.094 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.471 ' O ' ' C ' ' A' ' 20' ' ' ARG . 0.4 OUTLIER 69.35 0.53 2.92 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.418 -0.801 . . . . 0.0 110.786 179.332 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.5 ' O ' ' HG3' ' A' ' 20' ' ' ARG . 2.5 tpm_? 38.43 39.34 0.29 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.365 -0.834 . . . . 0.0 109.615 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.12 37.74 0.99 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.356 -0.84 . . . . 0.0 109.178 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.432 ' O ' HG12 ' A' ' 22' ' ' VAL . 72.4 t -141.04 72.92 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.417 -0.802 . . . . 0.0 109.64 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.584 ' H ' HD12 ' A' ' 23' ' ' ILE . 1.9 mp -99.17 43.96 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.16 -0.962 . . . . 0.0 109.426 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.59 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -143.18 106.3 4.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.429 -0.794 . . . . 0.0 109.365 179.888 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.59 ' HB3' ' O ' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.411 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.0 ttm . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -72.67 73.64 2.88 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.904 1.476 . . . . 0.0 110.325 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -169.26 159.71 32.75 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.76 ' O ' HG23 ' A' ' 4' ' ' THR . 14.6 t -101.17 56.38 0.85 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.359 -1.083 . . . . 0.0 109.023 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.737 ' H ' HD12 ' A' ' 5' ' ' ILE . 1.8 mp -84.66 43.21 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.455 -0.778 . . . . 0.0 109.656 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 5' ' ' ILE . 14.1 tttt 40.04 42.52 1.13 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.5 -0.75 . . . . 0.0 109.838 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.406 ' OE2' HG11 ' A' ' 12' ' ' VAL . 11.4 tt0 50.36 64.29 1.86 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.204 -0.935 . . . . 0.0 109.404 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -110.71 54.0 0.68 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.188 -0.945 . . . . 0.0 109.476 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.602 ' O ' HG22 ' A' ' 10' ' ' ILE . 8.9 mm -78.27 -3.09 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.285 -0.884 . . . . 0.0 109.651 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.771 ' O ' HG23 ' A' ' 10' ' ' ILE . 0.3 OUTLIER 56.36 33.1 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-O 122.071 0.939 . . . . 0.0 109.708 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -151.78 -40.44 0.03 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.468 ' O ' ' O ' ' A' ' 13' ' ' SER . 0.5 OUTLIER -96.23 -19.56 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.425 -1.044 . . . . 0.0 108.821 179.568 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 12' ' ' VAL . 0.2 OUTLIER -54.4 -168.07 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.084 -178.29 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -114.93 5.13 14.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.331 -0.855 . . . . 0.0 109.8 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.72 52.91 0.74 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.083 -1.01 . . . . 0.0 109.636 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.473 ' OE1' HG13 ' A' ' 10' ' ' ILE . 20.2 tt0 -163.32 -55.51 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.226 -0.921 . . . . 0.0 109.555 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.516 ' O ' ' N ' ' A' ' 20' ' ' ARG . 0.3 OUTLIER -129.22 21.78 5.69 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.111 -0.993 . . . . 0.0 109.678 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.504 ' C ' ' O ' ' A' ' 17' ' ' TYR . 0.4 OUTLIER 30.66 42.47 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.139 0.495 . . . . 0.0 110.708 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.492 ' O ' ' CD2' ' A' ' 19' ' ' TYR . 71.2 t80 52.69 43.59 31.13 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.182 -0.949 . . . . 0.0 109.521 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.518 ' CG ' ' O ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER 42.21 45.13 3.47 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.396 -0.815 . . . . 0.0 109.677 179.878 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.5 m -161.78 47.94 0.19 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.36 -0.838 . . . . 0.0 109.028 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 1.085 HG13 ' CD1' ' A' ' 23' ' ' ILE . 2.6 p -49.42 -25.27 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.397 -0.815 . . . . 0.0 109.657 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 1.085 ' CD1' HG13 ' A' ' 22' ' ' VAL . 1.5 mp -89.82 52.35 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 O-C-N 121.164 -0.96 . . . . 0.0 108.54 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.456 ' HD3' ' O ' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -76.22 149.01 37.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.132 -0.98 . . . . 0.0 109.338 -179.695 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.341 179.965 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 ttt . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 120.801 0.334 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -75.8 87.31 1.4 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.054 1.555 . . . . 0.0 110.616 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 128.38 137.45 4.38 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.851 -1.299 . . . . 0.0 109.851 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.802 HG23 ' HB2' ' A' ' 6' ' ' LYS . 8.9 t -93.92 36.61 1.1 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.19 -1.182 . . . . 0.0 109.287 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.57 HG23 ' O ' ' A' ' 5' ' ' ILE . 10.0 tp 33.2 48.34 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 121.324 0.583 . . . . 0.0 110.661 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.802 ' HB2' HG23 ' A' ' 4' ' ' THR . 3.1 tptt -119.56 48.93 1.43 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.113 -0.992 . . . . 0.0 109.432 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLU . . . . . 0.598 ' CG ' ' O ' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -109.73 24.8 12.55 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 122.19 0.995 . . . . 0.0 109.187 179.922 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.465 ' C ' HD12 ' A' ' 9' ' ' ILE . 20.0 t-20 -101.93 39.56 1.45 Allowed 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.24 -0.913 . . . . 0.0 109.909 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.762 HG22 HD12 ' A' ' 10' ' ' ILE . 4.2 mp -130.35 -64.43 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-O 121.877 0.846 . . . . 0.0 109.197 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.775 HG22 ' O ' ' A' ' 10' ' ' ILE . 0.9 OUTLIER -159.0 82.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.873 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 178.66 92.11 0.08 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.472 ' O ' ' O ' ' A' ' 13' ' ' SER . 87.9 t -95.29 -62.31 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.316 -1.108 . . . . 0.0 109.722 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.472 ' O ' ' O ' ' A' ' 12' ' ' VAL . 1.9 p -48.25 177.07 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.788 -178.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.44 ' CD2' ' O ' ' A' ' 14' ' ' TYR . 61.3 t80 -98.47 -1.51 41.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.33 -0.856 . . . . 0.0 109.664 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -108.86 29.24 7.65 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.235 -0.916 . . . . 0.0 109.665 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 58.75 9.7 1.24 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.548 -0.72 . . . . 0.0 110.864 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER 63.44 45.59 4.75 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 120.703 -1.248 . . . . 0.0 108.82 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.524 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -79.5 48.58 0.92 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.931 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.524 ' HB2' ' O ' ' A' ' 18' ' ' ARG . 0.5 OUTLIER 73.14 44.84 0.31 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.727 -0.608 . . . . 0.0 109.489 -179.426 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.453 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 0.1 OUTLIER -103.91 36.84 2.21 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.343 -0.848 . . . . 0.0 108.851 179.587 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -120.53 32.87 5.8 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.482 -0.761 . . . . 0.0 109.111 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.772 ' O ' HG12 ' A' ' 22' ' ' VAL . 95.4 t -92.27 46.23 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.633 -0.667 . . . . 0.0 109.546 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.851 HG22 ' O ' ' A' ' 23' ' ' ILE . 6.7 mm 29.75 63.12 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-O 122.01 0.91 . . . . 0.0 110.212 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.469 ' CB ' ' O ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER 165.19 -163.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.925 . . . . 0.0 109.202 -179.556 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.382 179.71 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 120.829 0.347 . . . . 0.0 110.295 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.01 -175.76 2.31 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.03 1.542 . . . . 0.0 110.397 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -103.44 146.63 16.52 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.49 ' O ' HG23 ' A' ' 4' ' ' THR . 12.3 t -103.1 44.92 0.98 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.337 -1.096 . . . . 0.0 109.78 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.779 HG23 ' O ' ' A' ' 5' ' ' ILE . 4.3 tp -95.59 40.51 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.239 -0.913 . . . . 0.0 109.746 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LYS . . . . . 0.494 ' CG ' ' O ' ' A' ' 5' ' ' ILE . 20.9 mtmt -158.11 56.86 0.47 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -0.921 . . . . 0.0 109.247 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -92.09 47.71 1.36 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.32 -0.862 . . . . 0.0 109.492 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.729 ' C ' HD12 ' A' ' 9' ' ' ILE . 25.8 t-20 -88.61 43.63 1.15 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.278 -0.889 . . . . 0.0 109.51 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.729 HD12 ' C ' ' A' ' 8' ' ' ASN . 2.3 mp -147.61 -54.02 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.272 -0.892 . . . . 0.0 109.183 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.627 HG13 HG22 ' A' ' 9' ' ' ILE . 13.6 mt -154.17 81.33 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -77.08 -2.85 79.87 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.696 HG12 ' N ' ' A' ' 13' ' ' SER . 55.9 t -74.61 -93.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.096 -1.238 . . . . 0.0 109.763 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.696 ' N ' HG12 ' A' ' 12' ' ' VAL . 0.7 OUTLIER 28.25 95.78 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 121.142 0.496 . . . . 0.0 110.987 -179.399 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.453 ' O ' ' C ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -84.67 -58.36 2.75 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.02 -1.05 . . . . 0.0 109.153 179.733 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.453 ' C ' ' O ' ' A' ' 14' ' ' TYR . 33.3 t0 40.02 40.43 0.75 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.634 -0.666 . . . . 0.0 109.774 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -173.79 -34.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.208 -0.933 . . . . 0.0 109.803 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.495 ' O ' ' N ' ' A' ' 20' ' ' ARG . 8.3 m-85 -117.79 31.68 6.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.171 -0.956 . . . . 0.0 109.468 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.479 ' C ' ' O ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER 31.87 49.41 0.12 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.217 0.532 . . . . 0.0 110.908 179.544 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.522 ' CG ' ' O ' ' A' ' 19' ' ' TYR . 11.3 t80 51.97 43.11 30.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.039 -1.038 . . . . 0.0 109.742 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.495 ' N ' ' O ' ' A' ' 17' ' ' TYR . 0.7 OUTLIER 46.88 65.46 1.22 Allowed 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.187 -0.946 . . . . 0.0 109.105 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 t -91.84 30.4 1.39 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.321 -0.862 . . . . 0.0 109.111 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.572 HG22 ' O ' ' A' ' 22' ' ' VAL . 9.7 p -77.88 0.97 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.654 -0.654 . . . . 0.0 109.547 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.2 mt -88.47 44.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.198 -0.939 . . . . 0.0 110.259 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.535 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -85.46 128.58 34.78 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.074 -1.016 . . . . 0.0 109.576 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.596 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.577 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 7.8 ttt . . . . . 0 N--CA 1.492 1.652 0 N-CA-C 111.099 0.037 . . . . 0.0 111.099 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 1' ' ' MET . 48.1 Cg_endo -78.11 -178.2 4.44 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.406 1.214 . . . . 0.0 110.426 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -121.21 160.0 15.64 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.653 ' O ' HG23 ' A' ' 4' ' ' THR . 15.2 t -95.6 50.71 1.24 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.27 -1.135 . . . . 0.0 109.469 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.469 ' O ' ' HB2' ' A' ' 8' ' ' ASN . 7.0 mm -85.52 44.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.227 -0.92 . . . . 0.0 109.27 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.9 mttt 53.43 51.1 15.98 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.172 -0.955 . . . . 0.0 109.001 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 51.27 62.84 2.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.346 -0.846 . . . . 0.0 108.893 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 5' ' ' ILE . 19.3 t30 -98.93 38.62 1.36 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.24 -0.912 . . . . 0.0 110.245 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.409 ' C ' HG12 ' A' ' 10' ' ' ILE . 37.6 mm -78.51 -11.06 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.133 -0.979 . . . . 0.0 108.544 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.702 HG22 ' O ' ' A' ' 10' ' ' ILE . 33.2 mm -150.8 51.52 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -91.34 27.01 9.98 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.349 -1.101 . . . . 0.0 110.349 -178.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.493 HG12 ' N ' ' A' ' 13' ' ' SER . 1.0 OUTLIER -48.9 -48.78 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.098 -1.236 . . . . 0.0 108.884 179.54 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.493 ' N ' HG12 ' A' ' 12' ' ' VAL . 90.5 p -43.65 119.82 1.79 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.529 -0.732 . . . . 0.0 109.727 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' TYR . . . . . 0.444 ' O ' ' C ' ' A' ' 15' ' ' ASP . 0.1 OUTLIER -82.58 -30.88 29.29 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.262 -0.898 . . . . 0.0 109.516 179.851 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 15' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 14' ' ' TYR . 24.8 t70 41.94 46.61 3.57 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.446 -0.784 . . . . 0.0 109.457 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.599 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 7.8 tt0 -96.25 -51.14 4.51 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.392 -0.817 . . . . 0.0 108.858 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' TYR . . . . . 0.599 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 3.1 m-85 -177.27 32.95 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ARG . . . . . 0.487 ' C ' ' O ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER 35.75 33.55 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.651 0.739 . . . . 0.0 109.791 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 19' ' ' TYR . . . . . 0.493 ' N ' ' O ' ' A' ' 17' ' ' TYR . 0.2 OUTLIER 52.56 24.01 2.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.655 -0.653 . . . . 0.0 109.869 -179.934 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . 0.471 ' O ' ' C ' ' A' ' 21' ' ' SER . 29.2 tpt85 -174.14 61.41 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.048 -1.032 . . . . 0.0 110.563 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.532 ' O ' ' CG1' ' A' ' 22' ' ' VAL . 10.7 t 38.78 64.07 0.82 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.538 -0.726 . . . . 0.0 109.765 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.585 HG22 ' O ' ' A' ' 22' ' ' VAL . 7.3 p 40.35 59.64 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 O-C-N 121.56 -0.713 . . . . 0.0 109.86 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.681 ' O ' HG23 ' A' ' 23' ' ' ILE . 8.3 tp 36.8 46.35 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.77 -0.581 . . . . 0.0 110.667 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.13 134.61 47.94 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.145 -0.972 . . . . 0.0 109.584 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.482 179.974 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.494 ' OD1' HG21 ' A' ' 12' ' ' VAL . 41.6 t-20 . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.336 0.589 . . . . 0.0 109.602 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.524 ' O ' HG22 ' A' ' 9' ' ' ILE . 30.7 mm -100.27 0.98 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.38 -0.825 . . . . 0.0 109.144 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.427 HG12 ' O ' ' A' ' 10' ' ' ILE . 6.2 tt -71.83 44.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.375 -0.828 . . . . 0.0 110.923 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 53.16 79.81 0.08 OUTLIER Glycine 0 N--CA 1.489 2.189 0 O-C-N 121.063 -1.023 . . . . 0.0 110.601 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.739 HG12 ' N ' ' A' ' 13' ' ' SER . 0.9 OUTLIER -91.77 -67.29 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.252 -1.146 . . . . 0.0 108.14 178.703 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.739 ' N ' HG12 ' A' ' 12' ' ' VAL . 0.5 OUTLIER -75.15 105.15 6.02 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.712 -0.795 . . . . 0.0 108.978 179.865 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -85.89 -45.75 11.24 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.142 -0.974 . . . . 0.0 110.048 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -130.19 62.47 1.57 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.093 -1.004 . . . . 0.0 109.927 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' A' ' 17' ' ' TYR . 2.0 tt0 -155.23 17.93 0.42 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.122 -0.986 . . . . 0.0 109.757 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.46 ' HB2' ' O ' ' A' ' 16' ' ' GLU . 0.1 OUTLIER 171.76 41.94 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.239 -0.913 . . . . 0.0 109.195 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -92.78 51.27 1.68 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.394 -0.816 . . . . 0.0 109.522 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 48.48 30.03 2.26 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.289 -0.882 . . . . 0.0 109.535 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.354 0 O-C-N 121.221 -0.925 . . . . 0.0 108.991 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 . . . . . 0 N--CA 1.489 1.515 0 CA-C-O 121.405 0.621 . . . . 0.0 109.452 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.576 ' O ' HG22 ' A' ' 9' ' ' ILE . 37.1 mm -84.4 2.39 3.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.382 -0.824 . . . . 0.0 108.953 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.645 ' O ' HG23 ' A' ' 10' ' ' ILE . 14.0 tt -66.11 45.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.495 -0.753 . . . . 0.0 110.635 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 9' ' ' ILE . . . 45.27 73.67 0.27 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.9 t -65.41 -61.65 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.21 -1.17 . . . . 0.0 109.052 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.1 p -73.49 70.79 1.29 Allowed 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.459 -0.897 . . . . 0.0 109.863 -178.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.07 -2.37 58.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.901 . . . . 0.0 109.747 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -154.76 55.31 0.67 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.189 -0.944 . . . . 0.0 109.51 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -161.74 -39.89 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.374 -0.829 . . . . 0.0 109.177 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -93.26 42.33 1.1 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.302 -0.874 . . . . 0.0 109.309 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.1 38.03 19.71 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.242 -0.911 . . . . 0.0 109.259 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.458 ' O ' ' C ' ' A' ' 20' ' ' ARG . 0.3 OUTLIER 66.41 6.24 4.22 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.503 -0.748 . . . . 0.0 109.933 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.483 ' HG3' ' O ' ' A' ' 20' ' ' ARG . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.448 0 CA-C-O 121.522 0.677 . . . . 0.0 110.142 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.488 1.452 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.5 mp -99.21 -19.38 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.252 -0.905 . . . . 0.0 109.076 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.593 ' O ' HG23 ' A' ' 10' ' ' ILE . 0.4 OUTLIER -120.15 29.68 2.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-O 121.759 0.79 . . . . 0.0 109.389 179.835 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.485 ' O ' ' N ' ' A' ' 13' ' ' SER . . . 64.3 4.36 12.09 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.597 HG12 ' N ' ' A' ' 13' ' ' SER . 1.2 t 67.34 -53.94 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 120.976 -1.308 . . . . 0.0 109.633 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.597 ' N ' HG12 ' A' ' 12' ' ' VAL . 0.1 OUTLIER -74.97 88.61 2.36 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.497 -0.752 . . . . 0.0 109.718 -179.08 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.51 ' CG ' ' O ' ' A' ' 14' ' ' TYR . 17.0 t80 -146.89 48.07 1.15 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.244 -0.91 . . . . 0.0 109.637 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -120.86 38.46 4.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.166 -0.959 . . . . 0.0 109.504 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -145.83 40.58 1.18 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.534 ' CB ' ' HB2' ' A' ' 20' ' ' ARG . 0.1 OUTLIER 49.28 41.38 20.13 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.511 -0.743 . . . . 0.0 109.098 -179.245 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.538 ' O ' ' CB ' ' A' ' 19' ' ' TYR . 6.2 ttt180 42.32 59.16 2.77 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.538 ' CB ' ' O ' ' A' ' 18' ' ' ARG . 22.5 t80 78.94 62.21 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -178.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.534 ' HB2' ' CB ' ' A' ' 17' ' ' TYR . 29.6 ttp180 . . . . . 0 N--CA 1.493 1.698 0 O-C-N 121.35 -0.844 . . . . 0.0 110.73 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.464 ' O ' HD13 ' A' ' 9' ' ' ILE . 16.7 t30 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 121.197 0.522 . . . . 0.0 109.799 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.496 ' O ' ' C ' ' A' ' 10' ' ' ILE . 34.6 mm -122.89 -51.97 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.248 -0.907 . . . . 0.0 109.258 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.773 ' O ' HG23 ' A' ' 10' ' ' ILE . 9.2 tp 28.29 48.64 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.986 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 153.23 97.44 0.15 Allowed Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.594 -1.288 . . . . 0.0 110.097 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.81 HG12 ' N ' ' A' ' 13' ' ' SER . 2.5 t -105.93 -83.07 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.206 -1.173 . . . . 0.0 108.989 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.81 ' N ' HG12 ' A' ' 12' ' ' VAL . 0.1 OUTLIER -68.25 92.42 0.41 Allowed 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.899 -0.721 . . . . 0.0 109.672 -179.185 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.23 47.3 2.01 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.218 -0.926 . . . . 0.0 109.387 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.453 ' CG ' ' O ' ' A' ' 15' ' ' ASP . 7.2 t70 54.2 61.61 2.96 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.105 -0.997 . . . . 0.0 108.702 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.585 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.9 OUTLIER -69.27 -33.89 73.92 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.147 -0.971 . . . . 0.0 108.944 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.585 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 96.9 m-85 -159.55 26.44 0.19 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.246 -0.909 . . . . 0.0 109.899 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.521 ' C ' ' O ' ' A' ' 17' ' ' TYR . 2.9 ttm180 27.42 43.91 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 120.976 0.417 . . . . 0.0 111.02 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.465 ' N ' ' O ' ' A' ' 17' ' ' TYR . 0.4 OUTLIER 69.66 51.41 0.46 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.031 -1.043 . . . . 0.0 109.262 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.508 ' HB3' ' HB3' ' A' ' 17' ' ' TYR . 36.4 ttp180 . . . . . 0 C--N 1.304 -1.401 0 O-C-N 121.287 -0.883 . . . . 0.0 109.121 -179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.952 ' C ' HD12 ' A' ' 9' ' ' ILE . 25.4 t-20 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.344 0.593 . . . . 0.0 109.715 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.952 HD12 ' C ' ' A' ' 8' ' ' ASN . 4.0 mp -147.49 -51.97 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.347 -0.846 . . . . 0.0 109.107 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.481 ' O ' HG23 ' A' ' 10' ' ' ILE . 16.5 tt 35.43 42.68 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 121.355 0.598 . . . . 0.0 109.989 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.481 ' H ' HG22 ' A' ' 9' ' ' ILE . . . -96.54 -17.61 33.06 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.829 -1.309 . . . . 0.0 109.829 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.728 HG12 ' N ' ' A' ' 13' ' ' SER . 42.9 t -68.63 -92.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.174 -1.192 . . . . 0.0 109.432 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.728 ' N ' HG12 ' A' ' 12' ' ' VAL . 15.9 p 35.61 63.59 0.53 Allowed 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.166 0.508 . . . . 0.0 110.456 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.51 -53.71 2.63 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.261 -0.899 . . . . 0.0 109.276 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -131.76 46.85 2.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.4 -0.812 . . . . 0.0 109.174 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -82.44 -29.13 30.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.299 -0.876 . . . . 0.0 109.781 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.506 ' O ' ' C ' ' A' ' 18' ' ' ARG . 0.4 OUTLIER -112.58 42.2 1.88 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.21 -0.931 . . . . 0.0 109.716 -179.736 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.506 ' C ' ' O ' ' A' ' 17' ' ' TYR . 1.8 mpp_? 31.79 52.16 0.21 Allowed 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.25 0.547 . . . . 0.0 110.631 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.415 ' O ' ' C ' ' A' ' 20' ' ' ARG . 0.2 OUTLIER 48.17 60.28 3.71 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.272 -0.892 . . . . 0.0 109.206 -179.779 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.485 ' HG2' ' O ' ' A' ' 20' ' ' ARG . 1.7 ttm180 . . . . . 0 N--CA 1.49 1.535 0 O-C-N 121.505 -0.747 . . . . 0.0 109.637 179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 63.0 t30 . . . . . 0 N--CA 1.488 1.452 0 CA-C-O 121.285 0.564 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.723 HG23 ' HB ' ' A' ' 12' ' ' VAL . 2.0 mp -47.5 -26.64 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.144 -0.972 . . . . 0.0 108.819 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.479 ' O ' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER 33.31 35.76 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.371 0.605 . . . . 0.0 110.505 179.825 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.539 ' H ' HG22 ' A' ' 9' ' ' ILE . . . 95.14 100.14 1.76 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.723 ' HB ' HG23 ' A' ' 9' ' ' ILE . 2.1 t -126.48 -58.3 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.297 -1.119 . . . . 0.0 109.29 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.43 ' N ' HG12 ' A' ' 12' ' ' VAL . 1.9 p -56.58 -173.45 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.766 -178.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.99 -81.0 0.16 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.254 -0.903 . . . . 0.0 109.403 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.25 41.24 1.14 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -0.915 . . . . 0.0 109.677 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.461 ' O ' ' HB3' ' A' ' 17' ' ' TYR . 0.6 OUTLIER 54.21 18.2 1.72 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.284 -0.885 . . . . 0.0 109.793 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.461 ' HB3' ' O ' ' A' ' 16' ' ' GLU . 32.4 t80 69.02 38.97 1.86 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.144 -0.973 . . . . 0.0 109.451 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.428 ' O ' ' C ' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -88.77 42.59 1.09 Allowed 'General case' 0 C--N 1.3 -1.543 0 O-C-N 121.31 -0.869 . . . . 0.0 108.747 179.587 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.428 ' C ' ' O ' ' A' ' 18' ' ' ARG . 2.1 m-85 45.2 36.28 2.09 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.272 -0.893 . . . . 0.0 108.785 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.517 0 O-C-N 121.405 -0.81 . . . . 0.0 109.485 -179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 9' ' ' ILE . 30.0 t-20 . . . . . 0 N--CA 1.482 1.143 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.519 ' N ' ' OD1' ' A' ' 8' ' ' ASN . 31.2 mm -128.21 -7.55 3.8 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 O-C-N 121.464 -0.773 . . . . 0.0 109.973 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.484 ' O ' HG23 ' A' ' 10' ' ' ILE . 1.1 tt -83.06 46.31 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.133 -0.979 . . . . 0.0 109.547 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -145.66 -101.57 0.31 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.52 HG12 ' N ' ' A' ' 13' ' ' SER . 53.8 t -127.54 -84.77 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.337 -1.096 . . . . 0.0 109.634 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.52 ' N ' HG12 ' A' ' 12' ' ' VAL . 0.1 OUTLIER 56.41 118.09 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.652 0.739 . . . . 0.0 110.145 -179.57 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.564 ' CG ' ' O ' ' A' ' 14' ' ' TYR . 24.7 t80 43.34 41.13 2.95 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.544 -0.722 . . . . 0.0 110.195 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 19' ' ' TYR . 18.8 t0 40.89 63.42 1.18 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.362 -0.836 . . . . 0.0 109.767 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.72 -3.26 30.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.03 -1.044 . . . . 0.0 109.984 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.45 ' O ' ' C ' ' A' ' 18' ' ' ARG . 26.0 m-85 -124.21 39.36 3.99 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.06 -1.025 . . . . 0.0 109.777 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.469 ' O ' ' N ' ' A' ' 20' ' ' ARG . 0.5 OUTLIER 41.92 32.91 0.31 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.658 0.742 . . . . 0.0 109.297 179.938 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.531 ' N ' ' OD1' ' A' ' 15' ' ' ASP . 2.0 t80 41.05 26.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.659 -0.651 . . . . 0.0 110.028 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.495 ' C ' ' O ' ' A' ' 19' ' ' TYR . 1.2 ttp180 . . . . . 0 N--CA 1.494 1.742 0 CA-C-O 121.473 0.654 . . . . 0.0 110.104 179.674 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.756 ' C ' HD12 ' A' ' 9' ' ' ILE . 47.5 t-20 . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.223 0.535 . . . . 0.0 110.034 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.756 HD12 ' C ' ' A' ' 8' ' ' ASN . 1.6 mp -110.16 -7.69 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.276 -0.89 . . . . 0.0 109.005 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.627 HG22 ' O ' ' A' ' 9' ' ' ILE . 4.6 tt 41.94 44.76 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-O 121.575 0.702 . . . . 0.0 110.164 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -86.38 49.42 4.07 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.574 HG12 ' N ' ' A' ' 13' ' ' SER . 57.7 t -64.13 -87.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.422 -1.046 . . . . 0.0 109.98 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.574 ' N ' HG12 ' A' ' 12' ' ' VAL . 0.8 OUTLIER 43.99 95.1 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.362 0.601 . . . . 0.0 109.841 -179.27 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.592 ' CG ' ' O ' ' A' ' 14' ' ' TYR . 31.5 t80 -92.76 4.48 53.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 109.606 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.457 ' OD2' ' O ' ' A' ' 15' ' ' ASP . 6.6 t70 54.75 72.3 0.48 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.073 -1.017 . . . . 0.0 109.345 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.16 -13.86 37.43 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.525 ' O ' ' N ' ' A' ' 19' ' ' TYR . 16.0 t80 -123.49 69.01 1.02 Allowed 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 178.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.8 ttp85 -62.1 39.21 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.731 -0.606 . . . . 0.0 111.432 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.525 ' N ' ' O ' ' A' ' 17' ' ' TYR . 10.1 t80 -144.59 10.42 1.41 Allowed 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.454 ' CG ' ' O ' ' A' ' 20' ' ' ARG . 6.4 ttm180 . . . . . 0 N--CA 1.482 1.146 0 O-C-N 121.114 -0.991 . . . . 0.0 108.91 179.699 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.655 ' C ' HD12 ' A' ' 9' ' ' ILE . 39.1 t30 . . . . . 0 N--CA 1.49 1.531 0 CA-C-O 121.059 0.457 . . . . 0.0 109.92 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.856 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.3 mp -123.77 -31.14 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.039 -1.038 . . . . 0.0 109.881 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.516 ' C ' ' O ' ' A' ' 9' ' ' ILE . 0.6 OUTLIER 29.29 45.63 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 121.187 0.518 . . . . 0.0 110.66 179.773 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 9' ' ' ILE . . . -121.02 47.94 0.99 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.485 ' O ' ' N ' ' A' ' 14' ' ' TYR . 0.6 OUTLIER -81.91 -33.22 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.291 -1.123 . . . . 0.0 109.2 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 12' ' ' VAL . 7.4 m -42.41 97.08 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.936 -178.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.485 ' N ' ' O ' ' A' ' 12' ' ' VAL . 0.6 OUTLIER -121.58 -47.04 2.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.322 -0.861 . . . . 0.0 109.262 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.58 49.67 0.82 Allowed 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.263 -0.898 . . . . 0.0 109.098 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -48.36 -22.98 0.79 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.274 -0.891 . . . . 0.0 109.359 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.43 ' O ' ' C ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -114.86 37.55 3.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.202 -0.936 . . . . 0.0 109.304 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.43 ' C ' ' O ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER 39.75 33.07 0.12 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.569 -0.707 . . . . 0.0 110.094 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.471 ' O ' ' C ' ' A' ' 20' ' ' ARG . 0.4 OUTLIER 69.35 0.53 2.92 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.418 -0.801 . . . . 0.0 110.786 179.332 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.5 ' HG3' ' O ' ' A' ' 20' ' ' ARG . 2.5 tpm_? . . . . . 0 N--CA 1.489 1.482 0 O-C-N 121.365 -0.834 . . . . 0.0 109.615 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 . . . . . 0 N--CA 1.489 1.5 0 CA-C-O 121.376 0.608 . . . . 0.0 109.476 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.602 ' O ' HG22 ' A' ' 10' ' ' ILE . 8.9 mm -78.27 -3.09 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.285 -0.884 . . . . 0.0 109.651 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.771 ' O ' HG23 ' A' ' 10' ' ' ILE . 0.3 OUTLIER 56.36 33.1 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-O 122.071 0.939 . . . . 0.0 109.708 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -151.78 -40.44 0.03 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.468 ' O ' ' O ' ' A' ' 13' ' ' SER . 0.5 OUTLIER -96.23 -19.56 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.425 -1.044 . . . . 0.0 108.821 179.568 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 12' ' ' VAL . 0.2 OUTLIER -54.4 -168.07 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.084 -178.29 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -114.93 5.13 14.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.331 -0.855 . . . . 0.0 109.8 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.72 52.91 0.74 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.083 -1.01 . . . . 0.0 109.636 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.473 ' OE1' HG13 ' A' ' 10' ' ' ILE . 20.2 tt0 -163.32 -55.51 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.226 -0.921 . . . . 0.0 109.555 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.516 ' O ' ' N ' ' A' ' 20' ' ' ARG . 0.3 OUTLIER -129.22 21.78 5.69 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.111 -0.993 . . . . 0.0 109.678 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.504 ' C ' ' O ' ' A' ' 17' ' ' TYR . 0.4 OUTLIER 30.66 42.47 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.139 0.495 . . . . 0.0 110.708 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.492 ' CD2' ' O ' ' A' ' 19' ' ' TYR . 71.2 t80 52.69 43.59 31.13 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.182 -0.949 . . . . 0.0 109.521 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.518 ' CG ' ' O ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.401 0 O-C-N 121.396 -0.815 . . . . 0.0 109.677 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.465 ' C ' HD12 ' A' ' 9' ' ' ILE . 20.0 t-20 . . . . . 0 N--CA 1.491 1.597 0 CA-C-O 121.309 0.576 . . . . 0.0 109.909 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.762 HG22 HD12 ' A' ' 10' ' ' ILE . 4.2 mp -130.35 -64.43 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-O 121.877 0.846 . . . . 0.0 109.197 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.775 ' O ' HG22 ' A' ' 10' ' ' ILE . 0.9 OUTLIER -159.0 82.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.873 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 178.66 92.11 0.08 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.472 ' O ' ' O ' ' A' ' 13' ' ' SER . 87.9 t -95.29 -62.31 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.316 -1.108 . . . . 0.0 109.722 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.472 ' O ' ' O ' ' A' ' 12' ' ' VAL . 1.9 p -48.25 177.07 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.788 -178.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.44 ' CD2' ' O ' ' A' ' 14' ' ' TYR . 61.3 t80 -98.47 -1.51 41.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.33 -0.856 . . . . 0.0 109.664 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -108.86 29.24 7.65 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.235 -0.916 . . . . 0.0 109.665 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 58.75 9.7 1.24 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.548 -0.72 . . . . 0.0 110.864 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER 63.44 45.59 4.75 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 120.703 -1.248 . . . . 0.0 108.82 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.524 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -79.5 48.58 0.92 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.931 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.524 ' HB2' ' O ' ' A' ' 18' ' ' ARG . 0.5 OUTLIER 73.14 44.84 0.31 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.727 -0.608 . . . . 0.0 109.489 -179.426 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.453 ' HG2' ' O ' ' A' ' 20' ' ' ARG . 0.1 OUTLIER . . . . . 0 N--CA 1.487 1.405 0 O-C-N 121.343 -0.848 . . . . 0.0 108.851 179.587 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.729 ' C ' HD12 ' A' ' 9' ' ' ILE . 25.8 t-20 . . . . . 0 N--CA 1.491 1.604 0 CA-C-O 121.331 0.586 . . . . 0.0 109.51 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.729 HD12 ' C ' ' A' ' 8' ' ' ASN . 2.3 mp -147.61 -54.02 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.272 -0.892 . . . . 0.0 109.183 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.627 HG13 HG22 ' A' ' 9' ' ' ILE . 13.6 mt -154.17 81.33 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -77.08 -2.85 79.87 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.696 HG12 ' N ' ' A' ' 13' ' ' SER . 55.9 t -74.61 -93.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.096 -1.238 . . . . 0.0 109.763 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.696 ' N ' HG12 ' A' ' 12' ' ' VAL . 0.7 OUTLIER 28.25 95.78 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 121.142 0.496 . . . . 0.0 110.987 -179.399 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.453 ' O ' ' C ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -84.67 -58.36 2.75 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.02 -1.05 . . . . 0.0 109.153 179.733 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.453 ' C ' ' O ' ' A' ' 14' ' ' TYR . 33.3 t0 40.02 40.43 0.75 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.634 -0.666 . . . . 0.0 109.774 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -173.79 -34.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.208 -0.933 . . . . 0.0 109.803 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.495 ' O ' ' N ' ' A' ' 20' ' ' ARG . 8.3 m-85 -117.79 31.68 6.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.171 -0.956 . . . . 0.0 109.468 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.479 ' C ' ' O ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER 31.87 49.41 0.12 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.217 0.532 . . . . 0.0 110.908 179.544 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.522 ' O ' ' CG ' ' A' ' 19' ' ' TYR . 11.3 t80 51.97 43.11 30.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.039 -1.038 . . . . 0.0 109.742 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.495 ' N ' ' O ' ' A' ' 17' ' ' TYR . 0.7 OUTLIER . . . . . 0 C--N 1.306 -1.298 0 O-C-N 121.187 -0.946 . . . . 0.0 109.105 179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 19.3 t30 . . . . . 0 N--CA 1.488 1.451 0 CA-C-O 121.257 0.551 . . . . 0.0 110.245 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.409 ' C ' HG12 ' A' ' 10' ' ' ILE . 37.6 mm -78.51 -11.06 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.133 -0.979 . . . . 0.0 108.544 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.702 ' O ' HG22 ' A' ' 10' ' ' ILE . 33.2 mm -150.8 51.52 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -91.34 27.01 9.98 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.349 -1.101 . . . . 0.0 110.349 -178.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.493 HG12 ' N ' ' A' ' 13' ' ' SER . 1.0 OUTLIER -48.9 -48.78 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.098 -1.236 . . . . 0.0 108.884 179.54 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.493 ' N ' HG12 ' A' ' 12' ' ' VAL . 90.5 p -43.65 119.82 1.79 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.529 -0.732 . . . . 0.0 109.727 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' TYR . . . . . 0.444 ' O ' ' C ' ' A' ' 15' ' ' ASP . 0.1 OUTLIER -82.58 -30.88 29.29 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.262 -0.898 . . . . 0.0 109.516 179.851 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 14' ' ' TYR . 24.8 t70 41.94 46.61 3.57 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.446 -0.784 . . . . 0.0 109.457 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.599 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 7.8 tt0 -96.25 -51.14 4.51 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.392 -0.817 . . . . 0.0 108.858 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' TYR . . . . . 0.599 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 3.1 m-85 -177.27 32.95 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ARG . . . . . 0.487 ' C ' ' O ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER 35.75 33.55 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.651 0.739 . . . . 0.0 109.791 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' TYR . . . . . 0.493 ' N ' ' O ' ' A' ' 17' ' ' TYR . 0.2 OUTLIER 52.56 24.01 2.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.655 -0.653 . . . . 0.0 109.869 -179.934 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ARG . . . . . 0.436 ' HD2' ' HA ' ' A' ' 20' ' ' ARG . 29.2 tpt85 . . . . . 0 N--CA 1.49 1.526 0 O-C-N 121.048 -1.032 . . . . 0.0 110.563 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 CA-C-O 120.677 0.275 . . . . 0.0 110.267 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -75.4 164.2 33.07 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 O-C-N 123.927 1.488 . . . . 0.0 110.333 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 92.52 -23.85 25.98 Favored Glycine 0 N--CA 1.491 2.333 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.803 HG23 ' O ' ' A' ' 4' ' ' THR . 7.1 t -119.69 58.26 0.89 Allowed 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.464 -1.021 . . . . 0.0 109.829 -179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.809 ' O ' HG23 ' A' ' 5' ' ' ILE . 1.1 tp -80.03 48.43 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.141 -0.975 . . . . 0.0 109.476 179.696 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -152.82 35.0 0.48 Allowed 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.196 -0.94 . . . . 0.0 108.911 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -169.16 70.64 0.07 Allowed 'General case' 0 C--N 1.3 -1.554 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.494 ' OD1' HG21 ' A' ' 12' ' ' VAL . 41.6 t-20 -80.99 45.62 0.84 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.508 -0.745 . . . . 0.0 109.602 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.524 ' O ' HG22 ' A' ' 9' ' ' ILE . 30.7 mm -100.27 0.98 10.48 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.38 -0.825 . . . . 0.0 109.144 179.749 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.427 HG12 ' O ' ' A' ' 10' ' ' ILE . 6.2 tt -71.83 44.6 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.79 0 O-C-N 121.375 -0.828 . . . . 0.0 110.923 -179.278 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 53.16 79.81 0.08 OUTLIER Glycine 0 N--CA 1.489 2.189 0 O-C-N 121.063 -1.023 . . . . 0.0 110.601 178.994 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.739 HG12 ' N ' ' A' ' 13' ' ' SER . 0.9 OUTLIER -91.77 -67.29 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.252 -1.146 . . . . 0.0 108.14 178.703 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.739 ' N ' HG12 ' A' ' 12' ' ' VAL . 0.5 OUTLIER -75.15 105.15 6.02 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.712 -0.795 . . . . 0.0 108.978 179.865 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -85.89 -45.75 11.24 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.142 -0.974 . . . . 0.0 110.048 -179.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -130.19 62.47 1.57 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.093 -1.004 . . . . 0.0 109.927 -179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.46 ' O ' ' HB2' ' A' ' 17' ' ' TYR . 2.0 tt0 -155.23 17.93 0.42 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.122 -0.986 . . . . 0.0 109.757 179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.46 ' HB2' ' O ' ' A' ' 16' ' ' GLU . 0.1 OUTLIER 171.76 41.94 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.239 -0.913 . . . . 0.0 109.195 179.855 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -92.78 51.27 1.68 Allowed 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.394 -0.816 . . . . 0.0 109.522 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . . . . . . . . . 39.9 m-85 48.48 30.03 2.26 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.289 -0.882 . . . . 0.0 109.535 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -106.44 39.38 1.83 Allowed 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.221 -0.925 . . . . 0.0 108.991 179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -107.61 31.65 5.28 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.492 -0.755 . . . . 0.0 109.124 179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.597 HG13 HG13 ' A' ' 23' ' ' ILE . 14.7 p -92.84 -0.96 10.37 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 O-C-N 121.64 -0.663 . . . . 0.0 109.39 179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.597 HG13 HG13 ' A' ' 22' ' ' VAL . 1.5 mp -122.52 42.2 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 O-C-N 121.187 -0.946 . . . . 0.0 109.377 179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -48.4 161.03 0.13 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.309 -0.869 . . . . 0.0 109.603 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.516 0 CA-C-O 118.047 -0.978 . . . . 0.0 109.406 179.962 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.546 ' N ' ' HD2' ' A' ' 2' ' ' PRO . 0.9 OUTLIER . . . . . 0 N--CA 1.495 1.791 0 N-CA-C 110.318 -0.253 . . . . 0.0 110.318 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.546 ' HD2' ' N ' ' A' ' 1' ' ' MET . 43.7 Cg_endo -72.18 -163.67 0.15 Allowed 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.741 1.39 . . . . 0.0 110.366 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -109.06 5.69 32.21 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.847 -1.301 . . . . 0.0 109.847 -179.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.535 HG23 ' O ' ' A' ' 4' ' ' THR . 15.2 t -86.1 43.65 1.07 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.204 -1.174 . . . . 0.0 109.729 -179.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.9 mm -110.02 44.6 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.174 -0.954 . . . . 0.0 109.159 179.825 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 179.29 51.26 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -96.3 58.41 1.79 Allowed 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.537 -0.727 . . . . 0.0 109.073 -179.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -76.45 47.71 0.49 Allowed 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.595 -0.691 . . . . 0.0 109.452 179.672 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.576 ' O ' HG22 ' A' ' 9' ' ' ILE . 37.1 mm -84.4 2.39 3.93 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.403 0 O-C-N 121.382 -0.824 . . . . 0.0 108.953 179.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.645 ' O ' HG23 ' A' ' 10' ' ' ILE . 14.0 tt -66.11 45.24 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 121.495 -0.753 . . . . 0.0 110.635 -179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.484 ' N ' ' O ' ' A' ' 9' ' ' ILE . . . 45.27 73.67 0.27 Allowed Glycine 0 N--CA 1.49 2.287 0 N-CA-C 110.036 -1.226 . . . . 0.0 110.036 179.299 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 9.9 t -65.41 -61.65 1.6 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.21 -1.17 . . . . 0.0 109.052 179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 78.1 p -73.49 70.79 1.29 Allowed 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.459 -0.897 . . . . 0.0 109.863 -178.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -86.07 -2.37 58.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.259 -0.901 . . . . 0.0 109.747 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -154.76 55.31 0.67 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.189 -0.944 . . . . 0.0 109.51 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -161.74 -39.89 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.374 -0.829 . . . . 0.0 109.177 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -93.26 42.33 1.1 Allowed 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.302 -0.874 . . . . 0.0 109.309 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.1 38.03 19.71 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.242 -0.911 . . . . 0.0 109.259 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.458 ' O ' ' C ' ' A' ' 20' ' ' ARG . 0.3 OUTLIER 66.41 6.24 4.22 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.503 -0.748 . . . . 0.0 109.933 179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.483 ' HG3' ' O ' ' A' ' 20' ' ' ARG . 0.2 OUTLIER 35.33 40.41 0.07 Allowed 'General case' 0 N--CA 1.488 1.448 0 CA-C-O 121.522 0.677 . . . . 0.0 110.142 179.634 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.7 p -105.12 37.45 2.18 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.209 -0.932 . . . . 0.0 108.932 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.645 ' O ' HG22 ' A' ' 22' ' ' VAL . 3.7 p -83.36 0.63 4.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.524 -0.735 . . . . 0.0 110.172 -179.607 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.533 ' O ' ' CB ' ' A' ' 24' ' ' LYS . 11.2 mm -94.8 32.85 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 120.966 -1.084 . . . . 0.0 109.615 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.533 ' CB ' ' O ' ' A' ' 23' ' ' ILE . 0.3 OUTLIER 158.37 56.4 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 N-CA-C 109.39 -0.596 . . . . 0.0 109.39 179.649 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.557 0 CA-C-O 117.967 -1.016 . . . . 0.0 109.457 -179.932 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.558 ' HB3' ' HD3' ' A' ' 2' ' ' PRO . 2.0 tpp . . . . . 0 N--CA 1.49 1.57 0 N-CA-C 110.671 -0.122 . . . . 0.0 110.671 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.558 ' HD3' ' HB3' ' A' ' 1' ' ' MET . 47.5 Cg_endo -74.54 105.2 2.01 Favored 'Trans proline' 0 C--N 1.313 -1.319 0 O-C-N 123.365 1.192 . . . . 0.0 110.377 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -157.58 166.58 33.86 Favored Glycine 0 N--CA 1.49 2.256 0 N-CA-C 109.834 -1.307 . . . . 0.0 109.834 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.0 t -89.89 40.21 0.99 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.344 -1.092 . . . . 0.0 109.55 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.657 ' O ' HG22 ' A' ' 5' ' ' ILE . 13.4 mt -112.23 40.8 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.245 -0.909 . . . . 0.0 109.335 179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -148.07 49.11 1.05 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.479 -0.763 . . . . 0.0 109.184 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 45.8 mt-10 50.38 62.6 2.6 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.356 -0.84 . . . . 0.0 109.406 -179.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -117.48 46.21 1.76 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.269 -0.895 . . . . 0.0 109.536 -179.791 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 1.5 mp -99.21 -19.38 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.252 -0.905 . . . . 0.0 109.076 179.859 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.593 ' O ' HG23 ' A' ' 10' ' ' ILE . 0.4 OUTLIER -120.15 29.68 2.6 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 CA-C-O 121.759 0.79 . . . . 0.0 109.389 179.835 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.485 ' O ' ' N ' ' A' ' 13' ' ' SER . . . 64.3 4.36 12.09 Favored Glycine 0 N--CA 1.493 2.469 0 N-CA-C 110.625 -0.99 . . . . 0.0 110.625 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.597 HG12 ' N ' ' A' ' 13' ' ' SER . 1.2 t 67.34 -53.94 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.359 0 O-C-N 120.976 -1.308 . . . . 0.0 109.633 179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.597 ' N ' HG12 ' A' ' 12' ' ' VAL . 0.1 OUTLIER -74.97 88.61 2.36 Favored 'General case' 0 C--N 1.299 -1.606 0 O-C-N 121.497 -0.752 . . . . 0.0 109.718 -179.08 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.51 ' CG ' ' O ' ' A' ' 14' ' ' TYR . 17.0 t80 -146.89 48.07 1.15 Allowed 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.244 -0.91 . . . . 0.0 109.637 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -120.86 38.46 4.04 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.166 -0.959 . . . . 0.0 109.504 179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 6.4 tt0 -145.83 40.58 1.18 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 179.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.534 ' CB ' ' HB2' ' A' ' 20' ' ' ARG . 0.1 OUTLIER 49.28 41.38 20.13 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.511 -0.743 . . . . 0.0 109.098 -179.245 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.538 ' O ' ' CB ' ' A' ' 19' ' ' TYR . 6.2 ttt180 42.32 59.16 2.77 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -179.773 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.538 ' CB ' ' O ' ' A' ' 18' ' ' ARG . 22.5 t80 78.94 62.21 0.03 OUTLIER 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -178.911 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.534 ' HB2' ' CB ' ' A' ' 17' ' ' TYR . 29.6 ttp180 -70.0 39.99 0.05 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.35 -0.844 . . . . 0.0 110.73 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.424 ' H ' ' C ' ' A' ' 19' ' ' TYR . 0.9 OUTLIER -117.38 22.61 12.34 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 178.659 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . . . . . . . . . 25.5 t -135.81 -28.04 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.141 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.0 mp -118.1 54.99 0.22 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.617 0 O-C-N 121.252 -0.905 . . . . 0.0 109.284 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 7.1 tttt -85.59 56.73 4.09 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.29 -0.882 . . . . 0.0 109.587 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.53 0 CA-C-O 118.02 -0.99 . . . . 0.0 109.508 179.862 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.0 mtm . . . . . 0 N--CA 1.492 1.661 0 CA-C-O 120.783 0.325 . . . . 0.0 110.241 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -73.91 171.84 17.08 Favored 'Trans proline' 0 C--N 1.306 -1.704 0 O-C-N 124.054 1.555 . . . . 0.0 110.423 -179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -105.06 -118.28 4.45 Favored Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 -179.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.531 ' O ' ' C ' ' A' ' 5' ' ' ILE . 13.9 t -106.06 34.62 3.25 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.212 -1.169 . . . . 0.0 109.491 -179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.852 HG22 ' O ' ' A' ' 5' ' ' ILE . 2.8 mp 23.66 58.08 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 CA-C-O 121.845 0.831 . . . . 0.0 110.839 179.401 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.431 ' O ' ' C ' ' A' ' 7' ' ' GLU . 12.6 mttt 44.64 45.28 7.93 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.24 -0.913 . . . . 0.0 110.279 179.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.531 ' N ' ' O ' ' A' ' 4' ' ' THR . 29.0 mt-10 41.17 56.58 3.03 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.303 -0.873 . . . . 0.0 110.053 179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.464 ' O ' HD13 ' A' ' 9' ' ' ILE . 16.7 t30 -115.49 43.39 2.07 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.107 -0.996 . . . . 0.0 109.799 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.496 ' O ' ' C ' ' A' ' 10' ' ' ILE . 34.6 mm -122.89 -51.97 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.248 -0.907 . . . . 0.0 109.258 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.773 ' O ' HG23 ' A' ' 10' ' ' ILE . 9.2 tp 28.29 48.64 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.979 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.986 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 153.23 97.44 0.15 Allowed Glycine 0 N--CA 1.491 2.359 0 C-N-CA 119.594 -1.288 . . . . 0.0 110.097 179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.81 HG12 ' N ' ' A' ' 13' ' ' SER . 2.5 t -105.93 -83.07 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.206 -1.173 . . . . 0.0 108.989 179.411 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.81 ' N ' HG12 ' A' ' 12' ' ' VAL . 0.1 OUTLIER -68.25 92.42 0.41 Allowed 'General case' 0 C--N 1.3 -1.554 0 C-N-CA 119.899 -0.721 . . . . 0.0 109.672 -179.185 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -123.23 47.3 2.01 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.218 -0.926 . . . . 0.0 109.387 179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.453 ' CG ' ' O ' ' A' ' 15' ' ' ASP . 7.2 t70 54.2 61.61 2.96 Favored 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.105 -0.997 . . . . 0.0 108.702 -179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.585 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 0.9 OUTLIER -69.27 -33.89 73.92 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.147 -0.971 . . . . 0.0 108.944 -179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.585 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 96.9 m-85 -159.55 26.44 0.19 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.246 -0.909 . . . . 0.0 109.899 179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.521 ' C ' ' O ' ' A' ' 17' ' ' TYR . 2.9 ttm180 27.42 43.91 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.14 0 CA-C-O 120.976 0.417 . . . . 0.0 111.02 179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.465 ' N ' ' O ' ' A' ' 17' ' ' TYR . 0.4 OUTLIER 69.66 51.41 0.46 Allowed 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.031 -1.043 . . . . 0.0 109.262 -179.917 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.508 ' HB3' ' HB3' ' A' ' 17' ' ' TYR . 36.4 ttp180 -90.82 40.24 1.01 Allowed 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.287 -0.883 . . . . 0.0 109.121 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -89.3 34.55 0.8 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.403 -0.81 . . . . 0.0 108.926 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.507 HG12 ' O ' ' A' ' 22' ' ' VAL . 46.3 t -130.65 59.41 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.51 -0.744 . . . . 0.0 109.685 -179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.821 HG22 ' O ' ' A' ' 23' ' ' ILE . 0.9 OUTLIER 37.38 73.52 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 CA-C-O 122.057 0.932 . . . . 0.0 109.942 179.182 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.472 ' O ' ' O ' ' A' ' 23' ' ' ILE . 10.2 mttp 43.39 99.54 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.415 -0.803 . . . . 0.0 110.586 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.097 -1.002 . . . . 0.0 109.173 179.38 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.548 ' HB3' ' HD3' ' A' ' 2' ' ' PRO . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.759 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.548 ' HD3' ' HB3' ' A' ' 1' ' ' MET . 44.0 Cg_endo -69.93 123.27 9.89 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.613 1.322 . . . . 0.0 110.468 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -89.14 -165.01 40.81 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.457 ' O ' ' C ' ' A' ' 5' ' ' ILE . 4.2 t -88.42 38.87 0.88 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.247 -1.149 . . . . 0.0 109.652 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.557 HG23 ' O ' ' A' ' 5' ' ' ILE . 8.1 tp 35.27 44.25 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.527 0 O-C-N 121.853 -0.529 . . . . 0.0 110.761 179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.516 ' O ' ' HB2' ' A' ' 7' ' ' GLU . 4.1 tptp -151.04 19.07 0.77 Allowed 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.947 -1.095 . . . . 0.0 109.943 179.775 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.516 ' HB2' ' O ' ' A' ' 6' ' ' LYS . 1.3 tt0 169.36 68.6 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.697 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.952 ' C ' HD12 ' A' ' 9' ' ' ILE . 25.4 t-20 -111.73 40.37 2.15 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.132 -0.98 . . . . 0.0 109.715 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.952 HD12 ' C ' ' A' ' 8' ' ' ASN . 4.0 mp -147.49 -51.97 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.347 -0.846 . . . . 0.0 109.107 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.481 ' O ' HG23 ' A' ' 10' ' ' ILE . 16.5 tt 35.43 42.68 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 CA-C-O 121.355 0.598 . . . . 0.0 109.989 179.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.481 ' H ' HG22 ' A' ' 9' ' ' ILE . . . -96.54 -17.61 33.06 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.829 -1.309 . . . . 0.0 109.829 -179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.728 HG12 ' N ' ' A' ' 13' ' ' SER . 42.9 t -68.63 -92.39 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.423 0 O-C-N 121.174 -1.192 . . . . 0.0 109.432 179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.728 ' N ' HG12 ' A' ' 12' ' ' VAL . 15.9 p 35.61 63.59 0.53 Allowed 'General case' 0 C--N 1.305 -1.35 0 CA-C-O 121.166 0.508 . . . . 0.0 110.456 -179.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -109.51 -53.71 2.63 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.261 -0.899 . . . . 0.0 109.276 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -131.76 46.85 2.59 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.4 -0.812 . . . . 0.0 109.174 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 -82.44 -29.13 30.86 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.299 -0.876 . . . . 0.0 109.781 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.506 ' O ' ' C ' ' A' ' 18' ' ' ARG . 0.4 OUTLIER -112.58 42.2 1.88 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.21 -0.931 . . . . 0.0 109.716 -179.736 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.506 ' C ' ' O ' ' A' ' 17' ' ' TYR . 1.8 mpp_? 31.79 52.16 0.21 Allowed 'General case' 0 N--CA 1.489 1.479 0 CA-C-O 121.25 0.547 . . . . 0.0 110.631 179.255 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.415 ' O ' ' C ' ' A' ' 20' ' ' ARG . 0.2 OUTLIER 48.17 60.28 3.71 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.272 -0.892 . . . . 0.0 109.206 -179.779 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.485 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 1.7 ttm180 41.45 50.96 3.71 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.505 -0.747 . . . . 0.0 109.637 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.449 ' C ' ' O ' ' A' ' 20' ' ' ARG . 74.3 m 39.39 54.44 2.31 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.529 -0.732 . . . . 0.0 110.243 179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.787 HG12 ' O ' ' A' ' 22' ' ' VAL . 78.3 t -110.29 44.89 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.238 -0.914 . . . . 0.0 109.07 179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.429 ' O ' ' C ' ' A' ' 24' ' ' LYS . 3.4 mp -131.48 64.57 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 O-C-N 121.235 -0.916 . . . . 0.0 109.242 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.429 ' C ' ' O ' ' A' ' 23' ' ' ILE . 21.2 ttpt -43.16 150.96 0.16 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.411 -0.806 . . . . 0.0 109.557 -179.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 117.988 -1.006 . . . . 0.0 109.464 -179.949 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.669 0 CA-C-O 120.839 0.352 . . . . 0.0 110.167 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -73.72 79.5 2.23 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.982 1.517 . . . . 0.0 110.38 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -99.1 -177.77 31.79 Favored Glycine 0 N--CA 1.492 2.384 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.761 HG23 ' O ' ' A' ' 4' ' ' THR . 4.7 t -117.74 44.42 2.17 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.172 -1.193 . . . . 0.0 109.871 -179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.762 HG22 ' O ' ' A' ' 5' ' ' ILE . 65.6 mt -128.51 67.78 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.143 -0.973 . . . . 0.0 109.767 -179.867 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -131.99 39.98 3.39 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.382 -0.824 . . . . 0.0 108.957 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -126.96 42.0 3.41 Favored 'General case' 0 C--N 1.302 -1.466 0 N-CA-C 108.964 -0.754 . . . . 0.0 108.964 179.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 63.0 t30 -98.78 43.81 1.05 Allowed 'General case' 0 C--N 1.301 -1.522 0 O-C-N 121.455 -0.778 . . . . 0.0 109.588 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.723 HG23 ' HB ' ' A' ' 12' ' ' VAL . 2.0 mp -47.5 -26.64 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 O-C-N 121.144 -0.972 . . . . 0.0 108.819 179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.479 ' O ' HG23 ' A' ' 10' ' ' ILE . 0.0 OUTLIER 33.31 35.76 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 CA-C-O 121.371 0.605 . . . . 0.0 110.505 179.825 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.539 ' H ' HG22 ' A' ' 9' ' ' ILE . . . 95.14 100.14 1.76 Allowed Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.713 -1.355 . . . . 0.0 109.713 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.723 ' HB ' HG23 ' A' ' 9' ' ' ILE . 2.1 t -126.48 -58.3 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.608 0 O-C-N 121.297 -1.119 . . . . 0.0 109.29 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.43 ' N ' HG12 ' A' ' 12' ' ' VAL . 1.9 p -56.58 -173.45 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.659 0 C-N-CA 119.778 -0.769 . . . . 0.0 109.766 -178.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -82.99 -81.0 0.16 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.254 -0.903 . . . . 0.0 109.403 179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.25 41.24 1.14 Allowed 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.235 -0.915 . . . . 0.0 109.677 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.461 ' O ' ' HB3' ' A' ' 17' ' ' TYR . 0.6 OUTLIER 54.21 18.2 1.72 Allowed 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.284 -0.885 . . . . 0.0 109.793 179.834 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.461 ' HB3' ' O ' ' A' ' 16' ' ' GLU . 32.4 t80 69.02 38.97 1.86 Allowed 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.144 -0.973 . . . . 0.0 109.451 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.428 ' O ' ' C ' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -88.77 42.59 1.09 Allowed 'General case' 0 C--N 1.3 -1.543 0 O-C-N 121.31 -0.869 . . . . 0.0 108.747 179.587 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.428 ' C ' ' O ' ' A' ' 18' ' ' ARG . 2.1 m-85 45.2 36.28 2.09 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.272 -0.893 . . . . 0.0 108.785 -179.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.9 37.48 0.97 Allowed 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.405 -0.81 . . . . 0.0 109.485 -179.879 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.4 m -144.2 28.8 1.34 Allowed 'General case' 0 N--CA 1.49 1.529 0 CA-C-O 121.806 0.812 . . . . 0.0 108.86 179.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.823 ' O ' HG13 ' A' ' 22' ' ' VAL . 9.9 p -119.35 62.77 0.21 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.589 0 CA-C-O 121.533 0.683 . . . . 0.0 109.401 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.831 HG23 ' O ' ' A' ' 23' ' ' ILE . 3.7 tp -76.59 41.89 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.075 -1.016 . . . . 0.0 110.708 -179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.409 ' HB2' ' O ' ' A' ' 23' ' ' ILE . 15.9 mtpt 62.53 73.22 0.47 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.662 -1.274 . . . . 0.0 109.308 179.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 117.933 -1.032 . . . . 0.0 109.477 -179.85 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.491 1.591 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -73.2 178.01 7.11 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 O-C-N 124.099 1.579 . . . . 0.0 110.337 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 133.96 -4.54 4.63 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.756 -1.338 . . . . 0.0 109.756 179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.439 ' O ' HD13 ' A' ' 5' ' ' ILE . 7.1 t -89.71 41.13 1.03 Allowed 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.192 -1.181 . . . . 0.0 109.291 179.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.439 HD13 ' O ' ' A' ' 4' ' ' THR . 19.4 mm -141.13 64.18 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.418 0 O-C-N 121.382 -0.824 . . . . 0.0 109.236 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.489 ' O ' ' CB ' ' A' ' 7' ' ' GLU . 0.3 OUTLIER -169.96 87.74 0.14 Allowed 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.332 -0.855 . . . . 0.0 109.048 -179.778 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.489 ' CB ' ' O ' ' A' ' 6' ' ' LYS . 17.4 mt-10 76.35 95.2 0.07 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.402 -0.811 . . . . 0.0 109.172 -179.547 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.519 ' OD1' ' N ' ' A' ' 9' ' ' ILE . 30.0 t-20 -99.82 -111.79 0.18 Allowed 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.438 -0.789 . . . . 0.0 109.03 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.519 ' N ' ' OD1' ' A' ' 8' ' ' ASN . 31.2 mm -128.21 -7.55 3.8 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 O-C-N 121.464 -0.773 . . . . 0.0 109.973 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.484 ' O ' HG23 ' A' ' 10' ' ' ILE . 1.1 tt -83.06 46.31 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.133 -0.979 . . . . 0.0 109.547 -179.857 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -145.66 -101.57 0.31 Allowed Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.52 HG12 ' N ' ' A' ' 13' ' ' SER . 53.8 t -127.54 -84.77 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.337 -1.096 . . . . 0.0 109.634 -179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.52 ' N ' HG12 ' A' ' 12' ' ' VAL . 0.1 OUTLIER 56.41 118.09 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.623 0 CA-C-O 121.652 0.739 . . . . 0.0 110.145 -179.57 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.564 ' O ' ' CG ' ' A' ' 14' ' ' TYR . 24.7 t80 43.34 41.13 2.95 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.544 -0.722 . . . . 0.0 110.195 179.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.531 ' OD1' ' N ' ' A' ' 19' ' ' TYR . 18.8 t0 40.89 63.42 1.18 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.362 -0.836 . . . . 0.0 109.767 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -74.72 -3.26 30.44 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.03 -1.044 . . . . 0.0 109.984 -179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.45 ' O ' ' C ' ' A' ' 18' ' ' ARG . 26.0 m-85 -124.21 39.36 3.99 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.06 -1.025 . . . . 0.0 109.777 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.61 ' O ' HG23 ' A' ' 22' ' ' VAL . 0.5 OUTLIER 41.92 32.91 0.31 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.658 0.742 . . . . 0.0 109.297 179.938 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.531 ' N ' ' OD1' ' A' ' 15' ' ' ASP . 2.0 t80 41.05 26.32 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.659 -0.651 . . . . 0.0 110.028 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.512 ' O ' ' HB2' ' A' ' 21' ' ' SER . 1.2 ttp180 33.07 40.18 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 CA-C-O 121.473 0.654 . . . . 0.0 110.104 179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.512 ' HB2' ' O ' ' A' ' 20' ' ' ARG . 25.8 t 168.13 52.85 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.468 -0.77 . . . . 0.0 109.409 -179.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.675 HG12 ' O ' ' A' ' 22' ' ' VAL . 96.9 t -112.46 59.86 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.096 -1.002 . . . . 0.0 109.57 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.674 ' N ' HD12 ' A' ' 23' ' ' ILE . 4.5 mp -134.73 61.08 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.362 -0.836 . . . . 0.0 109.459 179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.425 ' O ' ' HG3' ' A' ' 24' ' ' LYS . 8.0 tptp 48.72 82.26 0.04 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.222 -0.924 . . . . 0.0 109.409 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.4 ' O ' ' O ' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.488 1.456 0 CA-C-O 118.011 -0.995 . . . . 0.0 109.524 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 mtt . . . . . 0 N--CA 1.492 1.656 0 N-CA-C 110.205 -0.295 . . . . 0.0 110.205 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -74.69 78.27 2.83 Favored 'Trans proline' 0 C--N 1.307 -1.649 0 O-C-N 123.96 1.505 . . . . 0.0 110.229 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -164.44 169.16 39.12 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.608 HG23 ' O ' ' A' ' 4' ' ' THR . 14.8 t -86.12 47.7 1.5 Allowed 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.264 -1.139 . . . . 0.0 109.432 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.549 HD13 ' C ' ' A' ' 4' ' ' THR . 4.0 mm -106.59 56.63 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.302 -0.874 . . . . 0.0 109.566 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.444 ' HG2' ' O ' ' A' ' 5' ' ' ILE . 0.1 OUTLIER -146.28 71.42 1.25 Allowed 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.276 -0.89 . . . . 0.0 109.196 179.988 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 4.4 tt0 -86.58 50.57 2.03 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.43 -0.794 . . . . 0.0 109.128 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.756 ' C ' HD12 ' A' ' 9' ' ' ILE . 47.5 t-20 -81.09 43.76 0.73 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.322 -0.861 . . . . 0.0 110.034 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.756 HD12 ' C ' ' A' ' 8' ' ' ASN . 1.6 mp -110.16 -7.69 11.44 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.276 -0.89 . . . . 0.0 109.005 179.6 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.627 HG22 ' O ' ' A' ' 9' ' ' ILE . 4.6 tt 41.94 44.76 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.429 0 CA-C-O 121.575 0.702 . . . . 0.0 110.164 179.726 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -86.38 49.42 4.07 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.339 -1.504 . . . . 0.0 109.339 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.574 HG12 ' N ' ' A' ' 13' ' ' SER . 57.7 t -64.13 -87.91 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.563 0 O-C-N 121.422 -1.046 . . . . 0.0 109.98 -179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.574 ' N ' HG12 ' A' ' 12' ' ' VAL . 0.8 OUTLIER 43.99 95.1 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.362 0.601 . . . . 0.0 109.841 -179.27 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.592 ' O ' ' CG ' ' A' ' 14' ' ' TYR . 31.5 t80 -92.76 4.48 53.7 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.26 -0.9 . . . . 0.0 109.606 -179.769 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.457 ' OD2' ' O ' ' A' ' 15' ' ' ASP . 6.6 t70 54.75 72.3 0.48 Allowed 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.073 -1.017 . . . . 0.0 109.345 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -89.16 -13.86 37.43 Favored 'General case' 0 C--N 1.301 -1.505 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 179.226 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.525 ' O ' ' N ' ' A' ' 19' ' ' TYR . 16.0 t80 -123.49 69.01 1.02 Allowed 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 178.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . . . . . . . . . 10.8 ttp85 -62.1 39.21 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.731 -0.606 . . . . 0.0 111.432 -178.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.525 ' N ' ' O ' ' A' ' 17' ' ' TYR . 10.1 t80 -144.59 10.42 1.41 Allowed 'General case' 0 C--N 1.3 -1.559 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 178.59 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.454 ' CG ' ' O ' ' A' ' 20' ' ' ARG . 6.4 ttm180 -79.55 50.01 1.08 Allowed 'General case' 0 N--CA 1.482 1.146 0 O-C-N 121.114 -0.991 . . . . 0.0 108.91 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.1 t -78.65 45.39 0.58 Allowed 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.124 -0.985 . . . . 0.0 109.011 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.678 HG12 ' O ' ' A' ' 22' ' ' VAL . 62.9 t -81.33 11.5 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.285 -0.884 . . . . 0.0 109.859 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.778 ' H ' HD12 ' A' ' 23' ' ' ILE . 3.7 mp -84.29 44.44 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.115 -0.99 . . . . 0.0 109.599 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.0 mtpt -147.99 -179.98 7.31 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.287 -0.883 . . . . 0.0 109.221 179.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 118.021 -0.99 . . . . 0.0 109.515 -179.906 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.524 ' CB ' ' HD3' ' A' ' 2' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.757 0 CA-C-O 120.809 0.338 . . . . 0.0 110.171 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.524 ' HD3' ' CB ' ' A' ' 1' ' ' MET . 47.3 Cg_endo -74.07 161.66 40.51 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 O-C-N 123.962 1.506 . . . . 0.0 110.58 -179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -136.15 -120.46 1.98 Allowed Glycine 0 N--CA 1.492 2.389 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.476 ' N ' HD12 ' A' ' 5' ' ' ILE . 8.8 t -95.83 42.48 1.09 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.251 -1.147 . . . . 0.0 109.413 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.608 ' N ' HD12 ' A' ' 5' ' ' ILE . 3.3 mp -131.63 68.74 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 O-C-N 121.238 -0.914 . . . . 0.0 109.415 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -124.14 56.89 1.24 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.248 -0.908 . . . . 0.0 109.608 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 49.28 63.59 2.09 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.224 -0.923 . . . . 0.0 109.546 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.655 ' C ' HD12 ' A' ' 9' ' ' ILE . 39.1 t30 -113.0 46.23 1.25 Allowed 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.238 -0.914 . . . . 0.0 109.92 -179.731 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.856 ' N ' HD12 ' A' ' 9' ' ' ILE . 3.3 mp -123.77 -31.14 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 121.039 -1.038 . . . . 0.0 109.881 179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.516 ' C ' ' O ' ' A' ' 9' ' ' ILE . 0.6 OUTLIER 29.29 45.63 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 121.187 0.518 . . . . 0.0 110.66 179.773 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 9' ' ' ILE . . . -121.02 47.94 0.99 Allowed Glycine 0 N--CA 1.49 2.289 0 N-CA-C 109.582 -1.407 . . . . 0.0 109.582 -179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.485 ' O ' ' N ' ' A' ' 14' ' ' TYR . 0.6 OUTLIER -81.91 -33.22 11.71 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.291 -1.123 . . . . 0.0 109.2 179.916 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.427 ' C ' ' O ' ' A' ' 12' ' ' VAL . 7.4 m -42.41 97.08 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.915 -0.714 . . . . 0.0 109.936 -178.553 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.485 ' N ' ' O ' ' A' ' 12' ' ' VAL . 0.6 OUTLIER -121.58 -47.04 2.23 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.322 -0.861 . . . . 0.0 109.262 179.906 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -103.58 49.67 0.82 Allowed 'General case' 0 C--N 1.305 -1.368 0 O-C-N 121.263 -0.898 . . . . 0.0 109.098 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 26.6 tt0 -48.36 -22.98 0.79 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.274 -0.891 . . . . 0.0 109.359 179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.43 ' O ' ' C ' ' A' ' 18' ' ' ARG . 0.0 OUTLIER -114.86 37.55 3.42 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.202 -0.936 . . . . 0.0 109.304 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.43 ' C ' ' O ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER 39.75 33.07 0.12 Allowed 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.569 -0.707 . . . . 0.0 110.094 179.977 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.471 ' O ' ' C ' ' A' ' 20' ' ' ARG . 0.4 OUTLIER 69.35 0.53 2.92 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.418 -0.801 . . . . 0.0 110.786 179.332 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.5 ' O ' ' HG3' ' A' ' 20' ' ' ARG . 2.5 tpm_? 38.43 39.34 0.29 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.365 -0.834 . . . . 0.0 109.615 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -92.12 37.74 0.99 Allowed 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.356 -0.84 . . . . 0.0 109.178 179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.432 ' O ' HG12 ' A' ' 22' ' ' VAL . 72.4 t -141.04 72.92 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.417 -0.802 . . . . 0.0 109.64 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.584 ' H ' HD12 ' A' ' 23' ' ' ILE . 1.9 mp -99.17 43.96 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.16 -0.962 . . . . 0.0 109.426 179.84 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.59 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -143.18 106.3 4.54 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.429 -0.794 . . . . 0.0 109.365 179.888 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.59 ' HB3' ' O ' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.489 1.521 0 CA-C-O 118.049 -0.977 . . . . 0.0 109.411 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 5.0 ttm . . . . . 0 N--CA 1.49 1.564 0 N-CA-C 110.089 -0.337 . . . . 0.0 110.089 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -72.67 73.64 2.88 Favored 'Trans proline' 0 C--N 1.305 -1.745 0 O-C-N 123.904 1.476 . . . . 0.0 110.325 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -169.26 159.71 32.75 Favored Glycine 0 N--CA 1.491 2.313 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.76 HG23 ' O ' ' A' ' 4' ' ' THR . 14.6 t -101.17 56.38 0.85 Allowed 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.359 -1.083 . . . . 0.0 109.023 179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.737 ' H ' HD12 ' A' ' 5' ' ' ILE . 1.8 mp -84.66 43.21 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.455 -0.778 . . . . 0.0 109.656 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.457 ' C ' ' O ' ' A' ' 5' ' ' ILE . 14.1 tttt 40.04 42.52 1.13 Allowed 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.5 -0.75 . . . . 0.0 109.838 179.784 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.406 ' OE2' HG11 ' A' ' 12' ' ' VAL . 11.4 tt0 50.36 64.29 1.86 Allowed 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.204 -0.935 . . . . 0.0 109.404 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 4.5 t-20 -110.71 54.0 0.68 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.188 -0.945 . . . . 0.0 109.476 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.602 ' O ' HG22 ' A' ' 10' ' ' ILE . 8.9 mm -78.27 -3.09 5.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.285 -0.884 . . . . 0.0 109.651 179.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.771 ' O ' HG23 ' A' ' 10' ' ' ILE . 0.3 OUTLIER 56.36 33.1 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.442 0 CA-C-O 122.071 0.939 . . . . 0.0 109.708 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -151.78 -40.44 0.03 OUTLIER Glycine 0 N--CA 1.49 2.267 0 N-CA-C 108.988 -1.645 . . . . 0.0 108.988 179.217 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.468 ' O ' ' O ' ' A' ' 13' ' ' SER . 0.5 OUTLIER -96.23 -19.56 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 O-C-N 121.425 -1.044 . . . . 0.0 108.821 179.568 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.468 ' O ' ' O ' ' A' ' 12' ' ' VAL . 0.2 OUTLIER -54.4 -168.07 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.608 0 C-N-CA 119.522 -0.871 . . . . 0.0 110.084 -178.29 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -114.93 5.13 14.99 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.331 -0.855 . . . . 0.0 109.8 -179.558 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -111.72 52.91 0.74 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.083 -1.01 . . . . 0.0 109.636 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.473 ' OE1' HG13 ' A' ' 10' ' ' ILE . 20.2 tt0 -163.32 -55.51 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.226 -0.921 . . . . 0.0 109.555 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.516 ' O ' ' N ' ' A' ' 20' ' ' ARG . 0.3 OUTLIER -129.22 21.78 5.69 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.111 -0.993 . . . . 0.0 109.678 -179.957 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.504 ' C ' ' O ' ' A' ' 17' ' ' TYR . 0.4 OUTLIER 30.66 42.47 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 CA-C-O 121.139 0.495 . . . . 0.0 110.708 179.865 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.492 ' O ' ' CD2' ' A' ' 19' ' ' TYR . 71.2 t80 52.69 43.59 31.13 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.182 -0.949 . . . . 0.0 109.521 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.518 ' CG ' ' O ' ' A' ' 20' ' ' ARG . 0.0 OUTLIER 42.21 45.13 3.47 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.396 -0.815 . . . . 0.0 109.677 179.878 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.5 m -161.78 47.94 0.19 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.36 -0.838 . . . . 0.0 109.028 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 1.085 HG13 ' CD1' ' A' ' 23' ' ' ILE . 2.6 p -49.42 -25.27 1.72 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.397 -0.815 . . . . 0.0 109.657 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 1.085 ' CD1' HG13 ' A' ' 22' ' ' VAL . 1.5 mp -89.82 52.35 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 O-C-N 121.164 -0.96 . . . . 0.0 108.54 179.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.456 ' O ' ' HD3' ' A' ' 24' ' ' LYS . 0.0 OUTLIER -76.22 149.01 37.28 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.132 -0.98 . . . . 0.0 109.338 -179.695 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 117.992 -1.004 . . . . 0.0 109.341 179.965 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 ttt . . . . . 0 N--CA 1.491 1.613 0 CA-C-O 120.801 0.334 . . . . 0.0 110.142 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 49.7 Cg_endo -75.8 87.31 1.4 Allowed 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.054 1.555 . . . . 0.0 110.616 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . 128.38 137.45 4.38 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.851 -1.299 . . . . 0.0 109.851 179.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.802 HG23 ' HB2' ' A' ' 6' ' ' LYS . 8.9 t -93.92 36.61 1.1 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.19 -1.182 . . . . 0.0 109.287 179.662 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.57 HG23 ' O ' ' A' ' 5' ' ' ILE . 10.0 tp 33.2 48.34 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 CA-C-O 121.324 0.583 . . . . 0.0 110.661 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.802 ' HB2' HG23 ' A' ' 4' ' ' THR . 3.1 tptt -119.56 48.93 1.43 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.113 -0.992 . . . . 0.0 109.432 179.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . 0.598 ' CG ' ' O ' ' A' ' 7' ' ' GLU . 0.1 OUTLIER -109.73 24.8 12.55 Favored 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 122.19 0.995 . . . . 0.0 109.187 179.922 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.465 ' C ' HD12 ' A' ' 9' ' ' ILE . 20.0 t-20 -101.93 39.56 1.45 Allowed 'General case' 0 C--N 1.297 -1.682 0 O-C-N 121.24 -0.913 . . . . 0.0 109.909 179.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.762 HG22 HD12 ' A' ' 10' ' ' ILE . 4.2 mp -130.35 -64.43 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 CA-C-O 121.877 0.846 . . . . 0.0 109.197 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.775 ' O ' HG22 ' A' ' 10' ' ' ILE . 0.9 OUTLIER -159.0 82.04 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.89 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 179.873 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . 178.66 92.11 0.08 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 -179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.472 ' O ' ' O ' ' A' ' 13' ' ' SER . 87.9 t -95.29 -62.31 1.87 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.316 -1.108 . . . . 0.0 109.722 -179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.472 ' O ' ' O ' ' A' ' 12' ' ' VAL . 1.9 p -48.25 177.07 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.592 0 C-N-CA 119.793 -0.763 . . . . 0.0 109.788 -178.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.44 ' CD2' ' O ' ' A' ' 14' ' ' TYR . 61.3 t80 -98.47 -1.51 41.15 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.33 -0.856 . . . . 0.0 109.664 -179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -108.86 29.24 7.65 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.235 -0.916 . . . . 0.0 109.665 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 58.75 9.7 1.24 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.548 -0.72 . . . . 0.0 110.864 179.352 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER 63.44 45.59 4.75 Favored 'General case' 0 C--N 1.306 -1.283 0 O-C-N 120.703 -1.248 . . . . 0.0 108.82 -179.51 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.524 ' O ' ' HB2' ' A' ' 19' ' ' TYR . 0.0 OUTLIER -79.5 48.58 0.92 Allowed 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 178.931 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.524 ' HB2' ' O ' ' A' ' 18' ' ' ARG . 0.5 OUTLIER 73.14 44.84 0.31 Allowed 'General case' 0 N--CA 1.487 1.392 0 O-C-N 121.727 -0.608 . . . . 0.0 109.489 -179.426 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.453 ' O ' ' HG2' ' A' ' 20' ' ' ARG . 0.1 OUTLIER -103.91 36.84 2.21 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.343 -0.848 . . . . 0.0 108.851 179.587 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -120.53 32.87 5.8 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.482 -0.761 . . . . 0.0 109.111 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.772 HG12 ' O ' ' A' ' 22' ' ' VAL . 95.4 t -92.27 46.23 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.633 -0.667 . . . . 0.0 109.546 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.851 HG22 ' O ' ' A' ' 23' ' ' ILE . 6.7 mm 29.75 63.12 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 CA-C-O 122.01 0.91 . . . . 0.0 110.212 179.349 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.469 ' CB ' ' O ' ' A' ' 23' ' ' ILE . 0.2 OUTLIER 165.19 -163.89 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.221 -0.925 . . . . 0.0 109.202 -179.556 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.954 -1.022 . . . . 0.0 109.382 179.71 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.648 0 CA-C-O 120.829 0.347 . . . . 0.0 110.295 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -74.01 -175.76 2.31 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.03 1.542 . . . . 0.0 110.397 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -103.44 146.63 16.52 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.49 HG23 ' O ' ' A' ' 4' ' ' THR . 12.3 t -103.1 44.92 0.98 Allowed 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.337 -1.096 . . . . 0.0 109.78 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.779 HG23 ' O ' ' A' ' 5' ' ' ILE . 4.3 tp -95.59 40.51 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.239 -0.913 . . . . 0.0 109.746 -179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . 0.494 ' CG ' ' O ' ' A' ' 5' ' ' ILE . 20.9 mtmt -158.11 56.86 0.47 Allowed 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.227 -0.921 . . . . 0.0 109.247 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -92.09 47.71 1.36 Allowed 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.32 -0.862 . . . . 0.0 109.492 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.729 ' C ' HD12 ' A' ' 9' ' ' ILE . 25.8 t-20 -88.61 43.63 1.15 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.278 -0.889 . . . . 0.0 109.51 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.729 HD12 ' C ' ' A' ' 8' ' ' ASN . 2.3 mp -147.61 -54.02 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.272 -0.892 . . . . 0.0 109.183 179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.627 HG13 HG22 ' A' ' 9' ' ' ILE . 13.6 mt -154.17 81.33 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.293 -1.855 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -179.804 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -77.08 -2.85 79.87 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 -179.365 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.696 HG12 ' N ' ' A' ' 13' ' ' SER . 55.9 t -74.61 -93.9 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.096 -1.238 . . . . 0.0 109.763 179.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.696 ' N ' HG12 ' A' ' 12' ' ' VAL . 0.7 OUTLIER 28.25 95.78 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 CA-C-O 121.142 0.496 . . . . 0.0 110.987 -179.399 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.453 ' O ' ' C ' ' A' ' 15' ' ' ASP . 0.0 OUTLIER -84.67 -58.36 2.75 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.02 -1.05 . . . . 0.0 109.153 179.733 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.453 ' C ' ' O ' ' A' ' 14' ' ' TYR . 33.3 t0 40.02 40.43 0.75 Allowed 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.634 -0.666 . . . . 0.0 109.774 179.711 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -173.79 -34.26 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.208 -0.933 . . . . 0.0 109.803 179.969 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.495 ' O ' ' N ' ' A' ' 20' ' ' ARG . 8.3 m-85 -117.79 31.68 6.57 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.171 -0.956 . . . . 0.0 109.468 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.479 ' C ' ' O ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER 31.87 49.41 0.12 Allowed 'General case' 0 N--CA 1.495 1.819 0 CA-C-O 121.217 0.532 . . . . 0.0 110.908 179.544 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.522 ' CG ' ' O ' ' A' ' 19' ' ' TYR . 11.3 t80 51.97 43.11 30.57 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.039 -1.038 . . . . 0.0 109.742 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.495 ' N ' ' O ' ' A' ' 17' ' ' TYR . 0.7 OUTLIER 46.88 65.46 1.22 Allowed 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.187 -0.946 . . . . 0.0 109.105 179.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 t -91.84 30.4 1.39 Allowed 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.321 -0.862 . . . . 0.0 109.111 179.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.572 ' O ' HG22 ' A' ' 22' ' ' VAL . 9.7 p -77.88 0.97 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.654 -0.654 . . . . 0.0 109.547 179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 3.2 mt -88.47 44.26 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.198 -0.939 . . . . 0.0 110.259 -179.502 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.535 ' O ' ' HB3' ' A' ' 25' ' ' ALA . 0.0 OUTLIER -85.46 128.58 34.78 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.074 -1.016 . . . . 0.0 109.576 179.968 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . 0.535 ' HB3' ' O ' ' A' ' 24' ' ' LYS . . . . . . . . 0 N--CA 1.492 1.654 0 CA-C-O 118.052 -0.975 . . . . 0.0 109.596 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.577 ' N ' ' CD ' ' A' ' 2' ' ' PRO . 7.8 ttt . . . . . 0 N--CA 1.492 1.652 0 N-CA-C 111.099 0.037 . . . . 0.0 111.099 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.577 ' CD ' ' N ' ' A' ' 1' ' ' MET . 48.1 Cg_endo -78.11 -178.2 4.44 Favored 'Trans proline' 0 C--N 1.313 -1.299 0 O-C-N 123.406 1.214 . . . . 0.0 110.426 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLY . . . . . . . . . . . . . . . -121.21 160.0 15.64 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.546 -1.421 . . . . 0.0 109.546 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.653 HG23 ' O ' ' A' ' 4' ' ' THR . 15.2 t -95.6 50.71 1.24 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.27 -1.135 . . . . 0.0 109.469 179.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.469 ' O ' ' HB2' ' A' ' 8' ' ' ASN . 7.0 mm -85.52 44.74 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.227 -0.92 . . . . 0.0 109.27 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LYS . . . . . . . . . . . . . 4.9 mttt 53.43 51.1 15.98 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.172 -0.955 . . . . 0.0 109.001 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLU . . . . . . . . . . . . . 15.5 mt-10 51.27 62.84 2.5 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.346 -0.846 . . . . 0.0 108.893 -179.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.469 ' HB2' ' O ' ' A' ' 5' ' ' ILE . 19.3 t30 -98.93 38.62 1.36 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.24 -0.912 . . . . 0.0 110.245 -179.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.409 ' C ' HG12 ' A' ' 10' ' ' ILE . 37.6 mm -78.51 -11.06 13.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 121.133 -0.979 . . . . 0.0 108.544 178.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.702 ' O ' HG22 ' A' ' 10' ' ' ILE . 33.2 mm -150.8 51.52 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.42 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 179.809 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . . . . . . . . . . . -91.34 27.01 9.98 Favored Glycine 0 N--CA 1.492 2.407 0 N-CA-C 110.349 -1.101 . . . . 0.0 110.349 -178.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.493 HG12 ' N ' ' A' ' 13' ' ' SER . 1.0 OUTLIER -48.9 -48.78 15.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 121.098 -1.236 . . . . 0.0 108.884 179.54 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.493 ' N ' HG12 ' A' ' 12' ' ' VAL . 90.5 p -43.65 119.82 1.79 Allowed 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.529 -0.732 . . . . 0.0 109.727 -179.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' TYR . . . . . 0.444 ' O ' ' C ' ' A' ' 15' ' ' ASP . 0.1 OUTLIER -82.58 -30.88 29.29 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.262 -0.898 . . . . 0.0 109.516 179.851 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' ASP . . . . . 0.444 ' C ' ' O ' ' A' ' 14' ' ' TYR . 24.8 t70 41.94 46.61 3.57 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.446 -0.784 . . . . 0.0 109.457 -179.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.599 ' O ' ' CG ' ' A' ' 17' ' ' TYR . 7.8 tt0 -96.25 -51.14 4.51 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.392 -0.817 . . . . 0.0 108.858 179.79 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' TYR . . . . . 0.599 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 3.1 m-85 -177.27 32.95 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ARG . . . . . 0.487 ' C ' ' O ' ' A' ' 17' ' ' TYR . 0.0 OUTLIER 35.75 33.55 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.765 0 CA-C-O 121.651 0.739 . . . . 0.0 109.791 -179.655 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' TYR . . . . . 0.493 ' N ' ' O ' ' A' ' 17' ' ' TYR . 0.2 OUTLIER 52.56 24.01 2.87 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.655 -0.653 . . . . 0.0 109.869 -179.934 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . 0.471 ' O ' ' C ' ' A' ' 21' ' ' SER . 29.2 tpt85 -174.14 61.41 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.048 -1.032 . . . . 0.0 110.563 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.532 ' O ' ' CG1' ' A' ' 22' ' ' VAL . 10.7 t 38.78 64.07 0.82 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.538 -0.726 . . . . 0.0 109.765 179.305 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.585 ' O ' HG22 ' A' ' 22' ' ' VAL . 7.3 p 40.35 59.64 0.2 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 O-C-N 121.56 -0.713 . . . . 0.0 109.86 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.681 HG23 ' O ' ' A' ' 23' ' ' ILE . 8.3 tp 36.8 46.35 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.77 -0.581 . . . . 0.0 110.667 179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.13 134.61 47.94 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.145 -0.972 . . . . 0.0 109.584 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.482 179.974 . . . . . . . . 0 0 . 1 stop_ save_